(self.webpackChunkcovid_science=self.webpackChunkcovid_science||[]).push([[579],{6355:(e,i,n)=>{"use strict";n.d(i,{Z:()=>s});var o,a=n(7294);n(600),e=n.hmd(e),(o="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.enterModule:void 0)&&o(e),"undefined"!=typeof reactHotLoaderGlobal&&reactHotLoaderGlobal.default.signature;var t=function(e){return a.createElement("div",{className:"annotation-container ".concat(e.visible&&"visible"," ").concat("Moderna"===e.content.vaccine&&"baseline-bottom"),style:{left:e.coords.x,top:e.coords.y},"data-v-2cfd9f41":""},a.createElement("div",{className:"vaccine","data-v-2cfd9f41":""},a.createElement("mark",{"data-v-2cfd9f41":""},e.content.vaccine)),a.createElement("div",{className:"title","data-v-2cfd9f41":""},e.content.title),a.createElement("div",{className:"journal","data-v-2cfd9f41":""},e.content.journal),a.createElement("div",{className:"date","data-v-2cfd9f41":""},e.content.date))},r=t;const s=r;var c,l;(c="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default:void 0)&&(c.register(t,"ArticleAnnotation","/Users/jeff/codeRepos/covid-science/src/components/Section3/ArticleAnnotation.jsx"),c.register(r,"default","/Users/jeff/codeRepos/covid-science/src/components/Section3/ArticleAnnotation.jsx")),(l="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.leaveModule:void 0)&&l(e)},9186:(e,i,n)=>{"use strict";n.d(i,{Z:()=>k});var o,a=n(7294),t=n(6355),r=n(33),s=n(1960),c=n(5128),l=n(5935),d=n(6129),u=n(9831),f=n(4991),m=n.n(f),p=n(317),v=n.n(p);function h(e,i){return function(e){if(Array.isArray(e))return e}(e)||function(e,i){if("undefined"!=typeof Symbol&&Symbol.iterator in Object(e)){var n=[],o=!0,a=!1,t=void 0;try{for(var r,s=e[Symbol.iterator]();!(o=(r=s.next()).done)&&(n.push(r.value),!i||n.length!==i);o=!0);}catch(e){a=!0,t=e}finally{try{o||null==s.return||s.return()}finally{if(a)throw t}}return n}}(e,i)||y(e,i)||function(){throw new TypeError("Invalid attempt to destructure non-iterable instance.\nIn order to be iterable, non-array objects must have a [Symbol.iterator]() method.")}()}function y(e,i){if(e){if("string"==typeof e)return g(e,i);var n=Object.prototype.toString.call(e).slice(8,-1);return"Object"===n&&e.constructor&&(n=e.constructor.name),"Map"===n||"Set"===n?Array.from(e):"Arguments"===n||/^(?:Ui|I)nt(?:8|16|32)(?:Clamped)?Array$/.test(n)?g(e,i):void 0}}function g(e,i){(null==i||i>e.length)&&(i=e.length);for(var n=0,o=new Array(i);n<i;n++)o[n]=e[n];return o}n(1530),e=n.hmd(e),(o="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.enterModule:void 0)&&o(e);var A="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default.signature:function(e){return e},b=(0,s.Z)().domain([0,2]).range([1e3,0]),S=(0,c._b)().domain([0,14e3]).range([1,40]),C={nodes:v().slice(1).map((function(e){return{id:e[0],title:e[1],journal:e[2],pubYear:+e[3],nodeGroup:e[4],nCitedBy:+e[5],r:S(+e[5])}})),links:m().slice(1).map((function(e,i){return{source:e[0],target:e[1],deg:e[2],idx:i}}))},R="33378609",w="33301246",N={vaccine:"Moderna",title:"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine",journal:"New England Journal of Medicine",date:"Dec 30 2020"},V={vaccine:"Pfizer",title:"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine",journal:"New England Journal of Medicine",date:"Dec 10 2020"},E=function(e){var i=(0,a.useRef)(),n=(0,a.useRef)(),o=h((0,a.useState)(!1),2),s=o[0],c=(o[1],h((0,a.useState)({x:0,y:0}),2)),f=c[0],m=c[1],p=h((0,a.useState)({x:0,y:0}),2),v=p[0],g=p[1],A=h((0,a.useState)(!1),2),S=A[0],E=A[1],I=h((0,a.useState)(null),2),k=I[0],x=I[1];return(0,a.useEffect)((function(){var o=i.current,a=(0,l.W)(e.visState,b),t=a.centerAt,r=a.zoom,c=a.forcesArr;o.d3Force("center",null),o.d3Force("charge",null),o.d3Force("link",null);var d,f=function(e,i){var n;if("undefined"==typeof Symbol||null==e[Symbol.iterator]){if(Array.isArray(e)||(n=y(e))){n&&(e=n);var o=0,a=function(){};return{s:a,n:function(){return o>=e.length?{done:!0}:{done:!1,value:e[o++]}},e:function(e){throw e},f:a}}throw new TypeError("Invalid attempt to iterate non-iterable instance.\nIn order to be iterable, non-array objects must have a [Symbol.iterator]() method.")}var t,r=!0,s=!1;return{s:function(){n=e[Symbol.iterator]()},n:function(){var e=n.next();return r=e.done,e},e:function(e){s=!0,t=e},f:function(){try{r||null==n.return||n.return()}finally{if(s)throw t}}}}(c);try{for(f.s();!(d=f.n()).done;){var m=d.value;o.d3Force(m.name,m.force)}}catch(e){f.e(e)}finally{f.f()}s||(0,u.Bt)(C,e.visState,n.current),o.d3ReheatSimulation(),o.centerAt(t[0],t[1],2e3),o.zoom(r,2e3),n.current=e.visState}),[e.visState]),a.createElement("div",{style:{cursor:S?"pointer":"auto"}},a.createElement(t.Z,{coords:f,visible:"state1"==e.visState,content:N}),a.createElement(t.Z,{coords:v,visible:"state1"==e.visState,content:V}),a.createElement(r.Z,{ref:i,graphData:C,linkColor:function(){return"rgba(255, 255, 255, .1)"},linkVisibility:(0,u.s3)(e.visState),linkCurvature:function(e){return e.source.y>e.target.y?-.2:.2},nodeColor:(0,d.y)(e.visState,k),nodeVisibility:(0,u.ai)(e.visState),nodeVal:(0,u.Ur)(e.visState),nodeCanvasObject:(0,u.YH)(e.visState,k),nodeCanvasObjectMode:function(){return"after"},nodeRelSize:1,onNodeHover:function(e){null!=e?(E(!0),x(e)):(E(!1),x(null))},nodeLabel:(0,u.gz)(e.visState),enableZoomPanInteraction:!1,enablePointerInteraction:!0,onNodeClick:function(e){window.open("https://pubmed.ncbi.nlm.nih.gov/".concat(e.id),"_blank")},onLinkClick:function(e){console.log(e)},onEngineTick:function(n){if("state1"==e.visState|"state2"==e.visState){var o=i.current;C.nodes.filter((function(e){return"0"==e.nodeGroup})).forEach((function(e){var i=o.graph2ScreenCoords(e.x,e.y);e.id===R?(i.x+=25,i.y-=110,m(i)):e.id===w&&(i.x+=25,i.y+=40,g(i))}))}},d3AlphaDecay:.06,d3VelocityDecay:.15}))};A(E,"useRef{fgRef}\nuseRef{visStateRef}\nuseState{[engineIsRunning, setEngineIsRunning](false)}\nuseState{[modernaCoords, setModernaCoords]({ x: 0, y: 0 })}\nuseState{[pfizerCoords, setPfizerCoords]({ x: 0, y: 0 })}\nuseState{[isHovered, setIsHovered](false)}\nuseState{[hoveredNode, setHoveredNode](null)}\nuseEffect{}");var I=E;const k=I;var x,z;(x="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default:void 0)&&(x.register(b,"xScale","/Users/jeff/codeRepos/covid-science/src/components/Section3/CiteGraph.jsx"),x.register(S,"rScale","/Users/jeff/codeRepos/covid-science/src/components/Section3/CiteGraph.jsx"),x.register(C,"graphData","/Users/jeff/codeRepos/covid-science/src/components/Section3/CiteGraph.jsx"),x.register(R,"modernaPMID","/Users/jeff/codeRepos/covid-science/src/components/Section3/CiteGraph.jsx"),x.register(w,"pfizerPMID","/Users/jeff/codeRepos/covid-science/src/components/Section3/CiteGraph.jsx"),x.register(N,"modernaAnnot","/Users/jeff/codeRepos/covid-science/src/components/Section3/CiteGraph.jsx"),x.register(V,"pfizerAnnot","/Users/jeff/codeRepos/covid-science/src/components/Section3/CiteGraph.jsx"),x.register(E,"CiteGraph","/Users/jeff/codeRepos/covid-science/src/components/Section3/CiteGraph.jsx"),x.register(I,"default","/Users/jeff/codeRepos/covid-science/src/components/Section3/CiteGraph.jsx")),(z="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.leaveModule:void 0)&&z(e)},8933:(e,i,n)=>{"use strict";n.d(i,{Z:()=>f});var o,a=n(7294),t=n(7067),r=n(7723);function s(e,i){(null==i||i>e.length)&&(i=e.length);for(var n=0,o=new Array(i);n<i;n++)o[n]=e[n];return o}n(5057),e=n.hmd(e),(o="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.enterModule:void 0)&&o(e);var c="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default.signature:function(e){return e},l={state1:"For instance, in December 2020, both Pfizer and Moderna published articles reporting the success of their phase 3 vaccine clinical trials, officially paving the way for approval and wide scale distribution.",state2:"Each of these articles cited some of the key prior work supporting the vaccine development (including earlier phase 1 & 2 trials, and non-human animal results).",state3:"And each of those supporting articles, in turn, cited prior work, including articles on the structural biology of SARS-CoV-2 virus, early candidate mRNA vaccines, and key insights from the previous SARS and MERS outbreaks. ",state4:"But these previous articles were not just important to the development of vaccines. Most of these articles went on to be cited by tens (or hundreds, or thousands) of subsequent articles, and collectively make up a tiny portion of the web of research surrounding coronaviruses and COVID-19."},d=function(e){var i,n,o=(i=(0,a.useState)(l.state1),n=2,function(e){if(Array.isArray(e))return e}(i)||function(e,i){if("undefined"!=typeof Symbol&&Symbol.iterator in Object(e)){var n=[],o=!0,a=!1,t=void 0;try{for(var r,s=e[Symbol.iterator]();!(o=(r=s.next()).done)&&(n.push(r.value),!i||n.length!==i);o=!0);}catch(e){a=!0,t=e}finally{try{o||null==s.return||s.return()}finally{if(a)throw t}}return n}}(i,n)||function(e,i){if(e){if("string"==typeof e)return s(e,i);var n=Object.prototype.toString.call(e).slice(8,-1);return"Object"===n&&e.constructor&&(n=e.constructor.name),"Map"===n||"Set"===n?Array.from(e):"Arguments"===n||/^(?:Ui|I)nt(?:8|16|32)(?:Clamped)?Array$/.test(n)?s(e,i):void 0}}(i,n)||function(){throw new TypeError("Invalid attempt to destructure non-iterable instance.\nIn order to be iterable, non-array objects must have a [Symbol.iterator]() method.")}()),c=o[0],d=o[1];return(0,a.useEffect)((function(){Object.keys(l).includes(e.visState)?d(l[e.visState]):console.log("no corresponding narrative for state: ".concat(e.visState))}),[e.visState]),a.createElement("div",{className:"graph-narrative-container","data-v-beb3c643":""},a.createElement(t.Z,{mode:"out-in","data-v-beb3c643":""},a.createElement(r.Z,{classNames:"fade",addEndListener:function(e,i){e.addEventListener("transitionend",i,!1)},key:c,"data-v-beb3c643":""},a.createElement("div",{className:"graph-narrative-text","data-v-beb3c643":""},a.createElement("p",{"data-v-beb3c643":""},c)))))};c(d,"useState{[text, setText](narrative['state1'])}\nuseEffect{}");var u=d;const f=u;var m,p;(m="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default:void 0)&&(m.register(l,"narrative","/Users/jeff/codeRepos/covid-science/src/components/Section3/GraphNarrative.jsx"),m.register(d,"GraphNarrative","/Users/jeff/codeRepos/covid-science/src/components/Section3/GraphNarrative.jsx"),m.register(u,"default","/Users/jeff/codeRepos/covid-science/src/components/Section3/GraphNarrative.jsx")),(p="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.leaveModule:void 0)&&p(e)},8766:(e,i,n)=>{"use strict";n.r(i),n.d(i,{default:()=>p});var o,a=n(7294),t=n(9186),r=n(8933),s=n(5716),c=n(7082);function l(e,i){(null==i||i>e.length)&&(i=e.length);for(var n=0,o=new Array(i);n<i;n++)o[n]=e[n];return o}n(1938),e=n.hmd(e),(o="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.enterModule:void 0)&&o(e);var d="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default.signature:function(e){return e};s.p8.registerPlugin(c.i);var u=["state1","state2","state3","state4"],f=function(e){var i,n,o=(i=(0,a.useState)("state1"),n=2,function(e){if(Array.isArray(e))return e}(i)||function(e,i){if("undefined"!=typeof Symbol&&Symbol.iterator in Object(e)){var n=[],o=!0,a=!1,t=void 0;try{for(var r,s=e[Symbol.iterator]();!(o=(r=s.next()).done)&&(n.push(r.value),!i||n.length!==i);o=!0);}catch(e){a=!0,t=e}finally{try{o||null==s.return||s.return()}finally{if(a)throw t}}return n}}(i,n)||function(e,i){if(e){if("string"==typeof e)return l(e,i);var n=Object.prototype.toString.call(e).slice(8,-1);return"Object"===n&&e.constructor&&(n=e.constructor.name),"Map"===n||"Set"===n?Array.from(e):"Arguments"===n||/^(?:Ui|I)nt(?:8|16|32)(?:Clamped)?Array$/.test(n)?l(e,i):void 0}}(i,n)||function(){throw new TypeError("Invalid attempt to destructure non-iterable instance.\nIn order to be iterable, non-array objects must have a [Symbol.iterator]() method.")}()),s=o[0],d=o[1],f=u.map((function(e,i){return a.createElement("div",{key:i,className:"visState ".concat(e),"data-v-840b4078":""})}));(0,a.useEffect)((function(){u.forEach((function(e,i){c.i.create({trigger:".".concat(e),start:"top center",end:"bottom center",onEnter:function(){return m(i)},onLeaveBack:function(){return m(i-1)}})}))}),[]),(0,a.useEffect)((function(){setTimeout((function(){c.i.refresh()}),3e3)}),[]);var m=function(e){e>=0&&d(u[e])};return a.createElement("div",{className:e.rootClassName,"data-v-840b4078":""},a.createElement("div",{className:"narrative-text","data-v-840b4078":""},a.createElement("div",{className:"section-break","data-v-840b4078":""}),a.createElement("p",{"data-v-840b4078":""},"Science is incremental, and the major headline-grabbing findings always stand on the shoulders of years of discoveries that came before. The time it took to develop vaccines for COVID-19 obliterated previous records â€” not because it was rushed, but because of the head start afforded by decades of prior research on other coronaviruses. By mid-March 2020, before most US cities had even announced their first lock downs, the first vaccine candidate was already"," ",a.createElement("a",{href:"https://www.nih.gov/news-events/news-releases/nih-clinical-trial-investigational-vaccine-covid-19-begins","data-v-840b4078":""},"entering clinical trial."," ")),a.createElement("p",{"data-v-840b4078":""},"Research articles formally acknowledge previous work via citations, which, when tracked, can establish the lineage of a scientific discovery. By tracing the lineage of an article's citations, you can begin to reveal the contours of the mountains of research that came before.")),a.createElement("div",{className:"section3-scroll-container","data-v-840b4078":""},a.createElement("div",{className:"graph-container","data-v-840b4078":""},a.createElement(r.Z,{visState:s,"data-v-840b4078":""}),a.createElement(t.Z,{visState:s,"data-v-840b4078":""})),f),a.createElement("div",{className:"narrative-text","data-v-840b4078":""},a.createElement("div",{className:"section-break","data-v-840b4078":""}),a.createElement("p",{"data-v-840b4078":""},"Confronted with the challenges of fighting an unknown virus, the scientific and medical communities dug in and armed themselves with the tool that's gotten us through similar challenges in the past: empirical research. New viruses prompt new questions, and the only way to answer these questions is by collecting the data, analyzing results, sharing findings, and debating the implications. The process is demanding, laborious, and meticulously methodical (read: slow). The volumes of information learned about COVID-19 in such a short time span are a testament to the scale of the research effort throughout 2020 and continuing today. The foundational research on earlier coronaviruses, coupled with the shift in resources and focus at the start of 2020, has enabled us to begin imagining a time beyond COVID-19. And will better prepare us for whatever comes next.")))};d(f,"useState{[currentVisState, setVisState]('state1')}\nuseEffect{}\nuseEffect{}");var m=f;const p=m;var v,h;(v="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default:void 0)&&(v.register(u,"visStates","/Users/jeff/codeRepos/covid-science/src/components/Section3/Section3.jsx"),v.register(f,"Section3","/Users/jeff/codeRepos/covid-science/src/components/Section3/Section3.jsx"),v.register(m,"default","/Users/jeff/codeRepos/covid-science/src/components/Section3/Section3.jsx")),(h="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.leaveModule:void 0)&&h(e)},6129:(e,i,n)=>{"use strict";n.d(i,{y:()=>u});var o,a=n(5128),t=n(8339);e=n.hmd(e),(o="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.enterModule:void 0)&&o(e),"undefined"!=typeof reactHotLoaderGlobal&&reactHotLoaderGlobal.default.signature;var r,s,c="33378609",l="33301246",d=(0,a._b)().domain([0,13e3]).range([t.Z.accent2,t.Z.accent1]),u=function(e,i){var n;switch(e){case"state1":n=function(e){return t.Z.accent1};break;case"state2":n=function(e){return e===i?"gray":[c,l].includes(e.id)?t.Z.accent1:t.Z.textColor};break;case"state3":n=function(e){return e===i?"gray":[c,l].includes(e.id)?t.Z.accent1:"2"===e.nodeGroup?t.Z.textColor:"rgba(255, 255, 255, .25)"};break;case"state4":n=function(e){return e===i?t.Z.textColor:d(e.nCitedBy)};break;default:n=function(e){return"rgba(255, 0, 0, 1)"}}return n};(r="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default:void 0)&&(r.register(c,"modernaPMID","/Users/jeff/codeRepos/covid-science/src/components/Section3/colors.js"),r.register(l,"pfizerPMID","/Users/jeff/codeRepos/covid-science/src/components/Section3/colors.js"),r.register(d,"colorScale","/Users/jeff/codeRepos/covid-science/src/components/Section3/colors.js"),r.register(u,"getNodeColorByState","/Users/jeff/codeRepos/covid-science/src/components/Section3/colors.js")),(s="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.leaveModule:void 0)&&s(e)},1448:(e,i,n)=>{"use strict";n.d(i,{z:()=>m});var o,a=n(6811),t=n(1112),r=n(6464),s=n(2878),c=n(2289);n(4880),e=n.hmd(e),(o="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.enterModule:void 0)&&o(e),"undefined"!=typeof reactHotLoaderGlobal&&reactHotLoaderGlobal.default.signature;var l,d,u="33378609",f="33301246",m=function(e,i){switch(e){case"state1":return[{name:"charge",force:(0,a.Z)().strength(-15).distanceMax(500)},{name:"collide",force:(0,t.Z)().radius(5).strength(1)},{name:"x",force:(0,r.Z)().x((function(e){return i(e.nodeGroup)})).strength(.5)},{name:"y",force:(0,s.Z)().y((function(e){return e.id===u?-10:e.id===f?10:0})).strength(.13)}];case"state2":case"state3":return[{name:"charge",force:(0,c.Z)().strength(-10).distanceMax(500)},{name:"collide",force:(0,t.Z)().radius(5).strength(1)},{name:"x",force:(0,r.Z)().x((function(e){return i(e.nodeGroup)})).strength(.5)},{name:"y",force:(0,s.Z)().y(0).strength(.13)}];case"state4":return[{name:"charge",force:(0,c.Z)().strength(-5).distanceMax(500).distanceMin(5)},{name:"x",force:(0,r.Z)().x((function(e){return i(e.nodeGroup)})).strength(.5)},{name:"y",force:(0,s.Z)().y(0).strength(.15)},{name:"collide",force:(0,t.Z)().radius((function(e){return 2*e.r})).strength(.4)}];case"state5":return[]}};(l="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default:void 0)&&(l.register(u,"modernaPMID","/Users/jeff/codeRepos/covid-science/src/components/Section3/forces.js"),l.register(f,"pfizerPMID","/Users/jeff/codeRepos/covid-science/src/components/Section3/forces.js"),l.register(m,"getForcesByState","/Users/jeff/codeRepos/covid-science/src/components/Section3/forces.js")),(d="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.leaveModule:void 0)&&d(e)},9831:(e,i,n)=>{"use strict";n.d(i,{ai:()=>s,s3:()=>c,Ur:()=>l,YH:()=>p,gz:()=>h,Bt:()=>y});var o,a=n(8602),t=n(1960),r=n(8339);e=n.hmd(e),(o="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.enterModule:void 0)&&o(e),"undefined"!=typeof reactHotLoaderGlobal&&reactHotLoaderGlobal.default.signature;var s=function(e){var i;switch(e){case"state1":i=function(e){return["0","9"].includes(e.nodeGroup)};break;case"state2":i=function(e){return["0","1"].includes(e.nodeGroup)};break;case"state3":case"state4":i=function(e){return["0","1","2"].includes(e.nodeGroup)};break;default:i=function(e){return!0}}return i},c=function(e){var i;switch(e){case"state1":i=function(e){return!1};break;case"state2":i=function(e){return"1"==e.deg};break;case"state3":case"state4":i=function(e){return["1","2"].includes(e.deg)};break;default:i=function(e){return!0}}return i},l=function(e){var i;switch(e){case"state1":i=function(e){return 25};case"state2":case"state3":i=function(e){return 25};break;case"state4":i=function(e){return Math.PI*Math.pow(e.r,2)};break;default:i=function(e){return e.r}}return i},d=(0,t.Z)().domain([1e3,14e3]).range([10,20]);window.innerWidth<768&&d.range([8,16]);var u,f,m=window.innerWidth>=768?1e3:3e3,p=function(e,i){var n;switch(e){case"state4":n=function(e,n,o){var t=e.nCitedBy,s=e.x,c=e.y;if(t<m)return null;var l=d(t)/o;n.font="".concat(l,"px Theinhardt-Med"),n.textAlign="center",n.textBaseline="middle",n.fillStyle=e===i?r.Z.bgColor:r.Z.textColor;var u=t<1e3?t:(0,a.WU)(".2s")(t);n.fillText(u,s,c)};break;default:n=function(){return null}}return n},v=function(e){var i=arguments.length>1&&void 0!==arguments[1]&&arguments[1];return i?'\n    <div class="cite-graph-tooltip-container '.concat("0"===e.nodeGroup?"left":"",'">\n      <div class="title">').concat(e.title,'</div>\n      <div class="journal">').concat(e.journal," <span>(").concat(e.pubYear,')</span></div>\n      <div class="break"></div>\n      <div class="cited-by">cited by <span>').concat(e.nCitedBy.toLocaleString(),"</span> articles</div>\n    </div>"):'\n        <div class="cite-graph-tooltip-container '.concat("0"===e.nodeGroup?"left":"",'">\n          <div class="title">').concat(e.title,'</div>\n          <div class="journal">').concat(e.journal," <span>(").concat(e.pubYear,")</span></div>\n        </div>")},h=function(e){var i;switch(e){case"state1":case"state2":case"state3":i=function(e){return v(e,!1)};break;case"state4":i=function(e){return v(e,!0)};break;default:i=function(){return null}}return i},y=function(e,i,n){var o=n>i?"up":"down";e.nodes.forEach((function(e){e.fx=void 0,e.fy=void 0})),e.nodes.filter((function(e){return"9"==e.nodeGroup})).forEach((function(e,i){switch(i){case 0:e.fx=0,e.fy=-500;break;case 1:e.fx=1e3,e.fy=-500;break;case 2:e.fx=1e3,e.fy=500;break;case 3:e.fx=0,e.fy=500}})),"state2"==i&&"up"==o&&e.nodes.filter((function(e){return"1"===e.nodeGroup})).forEach((function(e){e.fx=e.x,e.fy=e.y}))};(u="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default:void 0)&&(u.register(s,"getNodeVisibilityByState","/Users/jeff/codeRepos/covid-science/src/components/Section3/graphUtils.js"),u.register(c,"getLinkVisibilityByState","/Users/jeff/codeRepos/covid-science/src/components/Section3/graphUtils.js"),u.register(l,"getNodeSizeByState","/Users/jeff/codeRepos/covid-science/src/components/Section3/graphUtils.js"),u.register(d,"fontScale","/Users/jeff/codeRepos/covid-science/src/components/Section3/graphUtils.js"),u.register(m,"labelThresh","/Users/jeff/codeRepos/covid-science/src/components/Section3/graphUtils.js"),u.register(p,"getNodeObjByState","/Users/jeff/codeRepos/covid-science/src/components/Section3/graphUtils.js"),u.register(v,"generateToolTip","/Users/jeff/codeRepos/covid-science/src/components/Section3/graphUtils.js"),u.register(h,"getNodeTooltipByState","/Users/jeff/codeRepos/covid-science/src/components/Section3/graphUtils.js"),u.register(y,"fixNodesByState","/Users/jeff/codeRepos/covid-science/src/components/Section3/graphUtils.js")),(f="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.leaveModule:void 0)&&f(e)},5935:(e,i,n)=>{"use strict";n.d(i,{W:()=>c});var o,a=n(1448);e=n.hmd(e),(o="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.enterModule:void 0)&&o(e),"undefined"!=typeof reactHotLoaderGlobal&&reactHotLoaderGlobal.default.signature;var t,r,s=function(e){var i=window.innerWidth;switch(e){case"state1":if(i>=960)return 5;if(i>=480&i<960)return 4;if(i<480)return 3;break;case"state2":if(i>=960)return 1.5;if(i>=480&i<960)return 1.25;if(i<480)return.65;break;case"state3":if(i>=960)return.8;if(i>=480&i<960)return.6;if(i<480)return.35;break;case"state4":if(i>=960)return.65;if(i>=480&i<960)return.5;if(i<480)return.3}},c=function(e,i){var n=window.innerWidth<480?-100:0;switch(e){case"state1":return{centerAt:[i(-.1),0],zoom:s(e),forcesArr:(0,a.z)(e,i)};case"state2":return{centerAt:[i(.5),n],zoom:s(e),forcesArr:(0,a.z)("state2",i)};case"state3":return{centerAt:[i(1),n],zoom:s(e),forcesArr:(0,a.z)("state3",i)};case"state4":return{centerAt:[i(1.3),n],zoom:s(e),forcesArr:(0,a.z)("state4",i)};default:return{centerAt:[i(1),n],zoom:.65,forcesArr:(0,a.z)("state1",i)}}};(t="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.default:void 0)&&(t.register(s,"getZoom","/Users/jeff/codeRepos/covid-science/src/components/Section3/visStates.js"),t.register(c,"getVisStateProps","/Users/jeff/codeRepos/covid-science/src/components/Section3/visStates.js")),(r="undefined"!=typeof reactHotLoaderGlobal?reactHotLoaderGlobal.leaveModule:void 0)&&r(e)},2443:(e,i,n)=>{"use strict";n.r(i),n.d(i,{default:()=>s});var o=n(4015),a=n.n(o),t=n(3645),r=n.n(t)()(a());r.push([e.id,'.annotation-container[data-v-2cfd9f41]{position:absolute;display:flex;flex-direction:column;opacity:0;height:100px;width:100%;transition:opacity .5s;transition-delay:.7s}.annotation-container.visible[data-v-2cfd9f41]{opacity:1}.annotation-container.baseline-bottom[data-v-2cfd9f41]{justify-content:flex-end}.annotation-container .vaccine[data-v-2cfd9f41]{text-transform:capitalize;font-family:"Theinhardt-Med";font-size:1.2rem}.annotation-container .title[data-v-2cfd9f41]{font-family:"Musee-Bold";font-size:1.6rem}.annotation-container .journal[data-v-2cfd9f41]{font-family:"Musee-Regular";font-size:1.4rem}.annotation-container .date[data-v-2cfd9f41]{font-family:"Theinhardt-Thin";font-size:1.2rem}@media(min-width: 320px)and (max-width: 479px){.annotation-container[data-v-2cfd9f41]{width:250px}}',"",{version:3,sources:["webpack://./src/components/Section3/ArticleAnnotation.scoped.scss"],names:[],mappings:"AAAA,uCAAuC,iBAAiB,CAAC,YAAY,CAAC,qBAAqB,CAAC,SAAS,CAAC,YAAY,CAAC,UAAU,CAAC,sBAAsB,CAAC,oBAAoB,CAAC,+CAA+C,SAAS,CAAC,uDAAuD,wBAAwB,CAAC,gDAAgD,yBAAyB,CAAC,4BAA4B,CAAC,gBAAgB,CAAC,8CAA8C,wBAAwB,CAAC,gBAAgB,CAAC,gDAAgD,2BAA2B,CAAC,gBAAgB,CAAC,6CAA6C,6BAA6B,CAAC,gBAAgB,CAAC,+CAA+C,uCAAuC,WAAW,CAAC",sourcesContent:['.annotation-container[data-v-2cfd9f41]{position:absolute;display:flex;flex-direction:column;opacity:0;height:100px;width:100%;transition:opacity .5s;transition-delay:.7s}.annotation-container.visible[data-v-2cfd9f41]{opacity:1}.annotation-container.baseline-bottom[data-v-2cfd9f41]{justify-content:flex-end}.annotation-container .vaccine[data-v-2cfd9f41]{text-transform:capitalize;font-family:"Theinhardt-Med";font-size:1.2rem}.annotation-container .title[data-v-2cfd9f41]{font-family:"Musee-Bold";font-size:1.6rem}.annotation-container .journal[data-v-2cfd9f41]{font-family:"Musee-Regular";font-size:1.4rem}.annotation-container .date[data-v-2cfd9f41]{font-family:"Theinhardt-Thin";font-size:1.2rem}@media(min-width: 320px)and (max-width: 479px){.annotation-container[data-v-2cfd9f41]{width:250px}}'],sourceRoot:""}]);const s=r},4214:(e,i,n)=>{"use strict";n.r(i),n.d(i,{default:()=>s});var o=n(4015),a=n.n(o),t=n(3645),r=n.n(t)()(a());r.push([e.id,'.force-graph-container .graph-tooltip{position:absolute;background:rgba(0,0,0,0);visibility:hidden}@media(min-width: 320px)and (max-width: 479px){.force-graph-container{pointer-events:none}}.cite-graph-tooltip-container{position:absolute;width:300px;transform:translate(0%, 0%);background-color:rgba(255,253,232,.95);box-shadow:7px 7px 10px rgba(0,0,0,.2);padding:.8rem;border-radius:5px;border:solid 1px #1d253b;font-family:"Musee-Bold";color:#1d253b}.cite-graph-tooltip-container.left{transform:translate(-100%, 0px)}.cite-graph-tooltip-container .title{font-size:1.5rem;margin-bottom:.2rem}.cite-graph-tooltip-container .journal{font-size:1.3rem}.cite-graph-tooltip-container .break{width:100%;height:5px;border-bottom:solid 1px #1d253b}.cite-graph-tooltip-container .cited-by{color:#036063;font-family:"Theinhardt-Reg";font-size:1.3rem;margin-top:.3rem}.cite-graph-tooltip-container .cited-by span{font-family:"Theinhardt-Black";font-size:1.5rem;color:#036063}',"",{version:3,sources:["webpack://./src/components/Section3/CiteGraph.scss"],names:[],mappings:"AAAA,sCAAsC,iBAAiB,CAAC,wBAAwB,CAAC,iBAAiB,CAAC,+CAA+C,uBAAuB,mBAAmB,CAAC,CAAC,8BAA8B,iBAAiB,CAAC,WAAW,CAAC,2BAA2B,CAAC,sCAAsC,CAAC,sCAAsC,CAAC,aAAa,CAAC,iBAAiB,CAAC,wBAAwB,CAAC,wBAAwB,CAAC,aAAa,CAAC,mCAAmC,+BAA+B,CAAC,qCAAqC,gBAAgB,CAAC,mBAAmB,CAAC,uCAAuC,gBAAgB,CAAC,qCAAqC,UAAU,CAAC,UAAU,CAAC,+BAA+B,CAAC,wCAAwC,aAAa,CAAC,4BAA4B,CAAC,gBAAgB,CAAC,gBAAgB,CAAC,6CAA6C,8BAA8B,CAAC,gBAAgB,CAAC,aAAa",sourcesContent:['.force-graph-container .graph-tooltip{position:absolute;background:rgba(0,0,0,0);visibility:hidden}@media(min-width: 320px)and (max-width: 479px){.force-graph-container{pointer-events:none}}.cite-graph-tooltip-container{position:absolute;width:300px;transform:translate(0%, 0%);background-color:rgba(255,253,232,.95);box-shadow:7px 7px 10px rgba(0,0,0,.2);padding:.8rem;border-radius:5px;border:solid 1px #1d253b;font-family:"Musee-Bold";color:#1d253b}.cite-graph-tooltip-container.left{transform:translate(-100%, 0px)}.cite-graph-tooltip-container .title{font-size:1.5rem;margin-bottom:.2rem}.cite-graph-tooltip-container .journal{font-size:1.3rem}.cite-graph-tooltip-container .break{width:100%;height:5px;border-bottom:solid 1px #1d253b}.cite-graph-tooltip-container .cited-by{color:#036063;font-family:"Theinhardt-Reg";font-size:1.3rem;margin-top:.3rem}.cite-graph-tooltip-container .cited-by span{font-family:"Theinhardt-Black";font-size:1.5rem;color:#036063}'],sourceRoot:""}]);const s=r},5115:(e,i,n)=>{"use strict";n.r(i),n.d(i,{default:()=>s});var o=n(4015),a=n.n(o),t=n(3645),r=n.n(t)()(a());r.push([e.id,".graph-narrative-container[data-v-beb3c643]{width:100%;position:absolute;min-height:200px;display:flex;justify-content:center;align-items:center;margin:4rem auto;z-index:1}.graph-narrative-container .graph-narrative-text[data-v-beb3c643]{width:75%;max-width:720px;font-size:1.9rem;line-height:1.65;text-align:left}@media(min-width: 320px)and (max-width: 479px){.graph-narrative-container[data-v-beb3c643]{margin:1rem auto 4rem}.graph-narrative-container .graph-narrative-text[data-v-beb3c643]{font-size:1.6rem;line-height:1.55}}.fade-enter[data-v-beb3c643]{opacity:0}.fade-enter-active[data-v-beb3c643]{opacity:1;transition:opacity 300ms cubic-bezier(0.55, 0.085, 0.68, 0.53)}.fade-exit[data-v-beb3c643]{opacity:1}.fade-exit-active[data-v-beb3c643]{opacity:0;transition:opacity 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94)}","",{version:3,sources:["webpack://./src/components/Section3/GraphNarrative.scoped.scss"],names:[],mappings:"AAAA,4CAA4C,UAAU,CAAC,iBAAiB,CAAC,gBAAgB,CAAC,YAAY,CAAC,sBAAsB,CAAC,kBAAkB,CAAC,gBAAgB,CAAC,SAAS,CAAC,kEAAkE,SAAS,CAAC,eAAe,CAAC,gBAAgB,CAAC,gBAAgB,CAAC,eAAe,CAAC,+CAA+C,4CAA4C,qBAAqB,CAAC,kEAAkE,gBAAgB,CAAC,gBAAgB,CAAC,CAAC,6BAA6B,SAAS,CAAC,oCAAoC,SAAS,CAAC,8DAA8D,CAAC,4BAA4B,SAAS,CAAC,mCAAmC,SAAS,CAAC,6DAA6D",sourcesContent:[".graph-narrative-container[data-v-beb3c643]{width:100%;position:absolute;min-height:200px;display:flex;justify-content:center;align-items:center;margin:4rem auto;z-index:1}.graph-narrative-container .graph-narrative-text[data-v-beb3c643]{width:75%;max-width:720px;font-size:1.9rem;line-height:1.65;text-align:left}@media(min-width: 320px)and (max-width: 479px){.graph-narrative-container[data-v-beb3c643]{margin:1rem auto 4rem}.graph-narrative-container .graph-narrative-text[data-v-beb3c643]{font-size:1.6rem;line-height:1.55}}.fade-enter[data-v-beb3c643]{opacity:0}.fade-enter-active[data-v-beb3c643]{opacity:1;transition:opacity 300ms cubic-bezier(0.55, 0.085, 0.68, 0.53)}.fade-exit[data-v-beb3c643]{opacity:1}.fade-exit-active[data-v-beb3c643]{opacity:0;transition:opacity 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94)}"],sourceRoot:""}]);const s=r},2646:(e,i,n)=>{"use strict";n.r(i),n.d(i,{default:()=>s});var o=n(4015),a=n.n(o),t=n(3645),r=n.n(t)()(a());r.push([e.id,".section-3[data-v-840b4078]{width:100vw;margin:0;max-width:none;padding:0px;position:relative}.graph-container[data-v-840b4078]{position:sticky;overflow:hidden;z-index:0;top:0px;height:100vh}.section3-scroll-container[data-v-840b4078]{width:100%;height:100%;margin:auto}.visState[data-v-840b4078]{width:100%;height:100vh;margin-bottom:20px}.visState.state1[data-v-840b4078]{height:25vh}","",{version:3,sources:["webpack://./src/components/Section3/Section3.scoped.scss"],names:[],mappings:"AAAA,4BAA4B,WAAW,CAAC,QAAQ,CAAC,cAAc,CAAC,WAAW,CAAC,iBAAiB,CAAC,kCAAkC,eAAe,CAAC,eAAe,CAAC,SAAS,CAAC,OAAO,CAAC,YAAY,CAAC,4CAA4C,UAAU,CAAC,WAAW,CAAC,WAAW,CAAC,2BAA2B,UAAU,CAAC,YAAY,CAAC,kBAAkB,CAAC,kCAAkC,WAAW",sourcesContent:[".section-3[data-v-840b4078]{width:100vw;margin:0;max-width:none;padding:0px;position:relative}.graph-container[data-v-840b4078]{position:sticky;overflow:hidden;z-index:0;top:0px;height:100vh}.section3-scroll-container[data-v-840b4078]{width:100%;height:100%;margin:auto}.visState[data-v-840b4078]{width:100%;height:100vh;margin-bottom:20px}.visState.state1[data-v-840b4078]{height:25vh}"],sourceRoot:""}]);const s=r},4991:e=>{e.exports=[["source","target","deg"],["33306989","33378609","1"],["32731258","33378609","1"],["32722908","33378609","1"],["22095567","33378609","1"],["32702298","33378609","1"],["32756549","33378609","1"],["33077678","33301246","1"],["33053279","33301246","1"],["32150748","33301246","1"],["33139139","33378609","1"],["16731915","33378609","1"],["33217362","33378609","1"],["32663912","33378609","1"],["32075877","33301246","1"],["21937658","33378609","1"],["22032844","33378609","1"],["32877576","33378609","1"],["32926660","33378609","1"],["33053279","33378609","1"],["33220855","33378609","1"],["18797453","33301246","1"],["32273591","33378609","1"],["32702299","33378609","1"],["26465999","33378609","1"],["22536382","33378609","1"],["32991794","33378609","1"],["31828291","33301246","1"],["33301246","33378609","1"],["26264835","33301246","1"],["32227757","33378609","1"],["27626517","33378609","1"],["27269431","33378609","1"],["16195424","21937658","2"],["16461566","21937658","2"],["17200946","21937658","2"],["17194199","21937658","2"],["15024391","21937658","2"],["15054081","21937658","2"],["17108024","21937658","2"],["15096611","21937658","2"],["15314040","21937658","2"],["16214268","21937658","2"],["15530413","21937658","2"],["16213065","21937658","2"],["15695582","21937658","2"],["17037596","21937658","2"],["16505353","21937658","2"],["15827197","21937658","2"],["15837235","21937658","2"],["16121363","21937658","2"],["16968120","21937658","2"],["16873249","21937658","2"],["16195440","21937658","2"],["16862151","21937658","2"],["16169905","21937658","2"],["16690096","21937658","2"],["15655773","21937658","2"],["15731234","21937658","2"],["12781533","21937658","2"],["14963300","21937658","2"],["15695582","16731915","2"],["15650189","16731915","2"],["15642942","16731915","2"],["15577937","16731915","2"],["15530413","16731915","2"],["15507655","16731915","2"],["15708987","16731915","2"],["15504263","16731915","2"],["15381196","16731915","2"],["15367630","16731915","2"],["15356154","16731915","2"],["15220038","16731915","2"],["15220033","16731915","2"],["15210961","16731915","2"],["15474494","16731915","2"],["15731223","16731915","2"],["15749124","16731915","2"],["15755610","16731915","2"],["14752165","21937658","2"],["14569023","21937658","2"],["12781535","21937658","2"],["17222058","21937658","2"],["12734147","21937658","2"],["12184362","21937658","2"],["16254327","16731915","2"],["16195424","16731915","2"],["16169905","16731915","2"],["16166518","16731915","2"],["16101349","16731915","2"],["16035944","16731915","2"],["16022774","16731915","2"],["15814718","16731915","2"],["15791205","16731915","2"],["15016880","21937658","2"],["17227689","21937658","2"],["18199635","21937658","2"],["17499378","21937658","2"],["17194199","22536382","2"],["17108019","22536382","2"],["16497416","22536382","2"],["16476986","22536382","2"],["16322745","22536382","2"],["16214268","22536382","2"],["16195424","22536382","2"],["15324552","22536382","2"],["15205534","22536382","2"],["15016880","22536382","2"],["14681510","22536382","2"],["12865378","22536382","2"],["12690092","22536382","2"],["12690091","22536382","2"],["12682352","22536382","2"],["17416434","22536382","2"],["17917067","22536382","2"],["17928346","22536382","2"],["17931153","22536382","2"],["7962541","27269431","2"],["4305198","27269431","2"],["4305197","27269431","2"],["21937658","22536382","2"],["21762752","22536382","2"],["20883165","22536382","2"],["20406307","22536382","2"],["12671062","22536382","2"],["20374001","22536382","2"],["19297479","22536382","2"],["18941225","22536382","2"],["18824060","22536382","2"],["18753223","22536382","2"],["18463152","22536382","2"],["18191004","22536382","2"],["18018769","22536382","2"],["19345285","22536382","2"],["17416434","21937658","2"],["12235218","22536382","2"],["9175832","22536382","2"],["19079256","21937658","2"],["19036930","21937658","2"],["18981084","21937658","2"],["18941225","21937658","2"],["18824060","21937658","2"],["18753223","21937658","2"],["18656518","21937658","2"],["18582997","21937658","2"],["15194798","16731915","2"],["18018769","21937658","2"],["17620608","21937658","2"],["17537853","21937658","2"],["17515829","21937658","2"],["17515642","21937658","2"],["17507479","21937658","2"],["19176631","21937658","2"],["19181630","21937658","2"],["19234811","21937658","2"],["19420084","21937658","2"],["8901605","22536382","2"],["8627759","22536382","2"],["7836924","22536382","2"],["6754243","22536382","2"],["4305198","22536382","2"],["4305197","22536382","2"],["21755013","21937658","2"],["11711632","22536382","2"],["21703402","21937658","2"],["20977431","21937658","2"],["20960282","21937658","2"],["20883165","21937658","2"],["20876821","21937658","2"],["20110095","21937658","2"],["19888339","21937658","2"],["19800030","21937658","2"],["20980507","21937658","2"],["15194770","16731915","2"],["14996844","16731915","2"],["15155925","16731915","2"],["16670345","31828291","2"],["16586358","31828291","2"],["11599686","31828291","2"],["26038486","26264835","2"],["25540984","26264835","2"],["25359562","26264835","2"],["25233993","26264835","2"],["25078002","26264835","2"],["25027661","26264835","2"],["23799535","26264835","2"],["23542122","26264835","2"],["23306021","26264835","2"],["23296926","26264835","2"],["23296925","26264835","2"],["23159882","26264835","2"],["17913310","31828291","2"],["18991332","31828291","2"],["19879222","31828291","2"],["21632986","31828291","2"],["29402578","31828291","2"],["29109276","31828291","2"],["29069368","31828291","2"],["29066091","31828291","2"],["28935236","31828291","2"],["28636855","31828291","2"],["28635557","31828291","2"],["23051623","26264835","2"],["28428558","31828291","2"],["27061888","31828291","2"],["27025838","31828291","2"],["25714138","31828291","2"],["25697739","31828291","2"],["25119609","31828291","2"],["24667168","31828291","2"],["23824369","31828291","2"],["27346939","31828291","2"],["22908294","26264835","2"],["22782619","26264835","2"],["22278370","26264835","2"],["15208624","18797453","2"],["14976262","18797453","2"],["14976261","18797453","2"],["14729660","18797453","2"],["14567964","18797453","2"],["14564000","18797453","2"],["12927681","18797453","2"],["15233739","18797453","2"],["11607032","18797453","2"],["10918143","18797453","2"],["10037236","18797453","2"],["9518670","18797453","2"],["8559660","18797453","2"],["8552671","18797453","2"],["8522182","18797453","2"],["7839312","18797453","2"],["10918485","18797453","2"],["29409570","31828291","2"],["15268662","18797453","2"],["16039576","18797453","2"],["21890902","26264835","2"],["21150709","26264835","2"],["20461061","26264835","2"],["20080679","26264835","2"],["19609242","26264835","2"],["18797453","26264835","2"],["18438401","26264835","2"],["15547138","18797453","2"],["16111635","26264835","2"],["1889744","26264835","2"],["1546298","26264835","2"],["18071662","18797453","2"],["17932806","18797453","2"],["17038590","18797453","2"],["16732888","18797453","2"],["16111635","18797453","2"],["15670750","26264835","2"],["15161975","16731915","2"],["29471464","31828291","2"],["30551178","31828291","2"],["12690091","16731915","2"],["11162792","16731915","2"],["32079150","32150748","2"],["32064853","32150748","2"],["32046819","32150748","2"],["32003551","32150748","2"],["31995857","32150748","2"],["31986264","32150748","2"],["31986261","32150748","2"],["31978945","32150748","2"],["29348656","32150748","2"],["27775012","32150748","2"],["19598148","32150748","2"],["19393959","32150748","2"],["12925421","32150748","2"],["12690092","16731915","2"],["12711465","16731915","2"],["12730500","16731915","2"],["12730501","16731915","2"],["15150417","16731915","2"],["15096611","16731915","2"],["15078936","16731915","2"],["15043961","16731915","2"],["15024391","16731915","2"],["12574374","27269431","2"],["14983044","16731915","2"],["32065055","32075877","2"],["14963300","16731915","2"],["14715271","16731915","2"],["14675530","16731915","2"],["14670965","16731915","2"],["14647384","16731915","2"],["12958366","16731915","2"],["12774078","16731915","2"],["12748314","16731915","2"],["14752165","16731915","2"],["32057769","32075877","2"],["32015508","32075877","2"],["32015507","32075877","2"],["27578435","32075877","2"],["26935699","32075877","2"],["24040512","32075877","2"],["21325420","32075877","2"],["19321428","32075877","2"],["18562523","32075877","2"],["16954221","32075877","2"],["27617430","32075877","2"],["16597622","32075877","2"],["15264254","32075877","2"],["14647384","32075877","2"],["12885899","32075877","2"],["12393927","32075877","2"],["11121305","32075877","2"],["9814710","32075877","2"],["8254673","32075877","2"],["15572765","32075877","2"],["30216647","31828291","2"],["28008928","32075877","2"],["28393837","32075877","2"],["32007145","32075877","2"],["32007143","32075877","2"],["31996437","32075877","2"],["31995857","32075877","2"],["31986264","32075877","2"],["31986261","32075877","2"],["31591575","32075877","2"],["28165473","32075877","2"],["31534041","32075877","2"],["30712865","32075877","2"],["30356097","32075877","2"],["30102747","32075877","2"],["29872003","32075877","2"],["29513216","32075877","2"],["29073020","32075877","2"],["28807998","32075877","2"],["31504163","32075877","2"],["15286725","27269431","2"],["24850731","27269431","2"],["17344286","27269431","2"],["32663912","32991794","2"],["32640463","32991794","2"],["32555424","32991794","2"],["32540900","32991794","2"],["32526206","32991794","2"],["32434946","32991794","2"],["32289263","32991794","2"],["32214079","32991794","2"],["32015508","32991794","2"],["31351922","32991794","2"],["31079849","32991794","2"],["30501873","32991794","2"],["28931244","32991794","2"],["28807998","32991794","2"],["26802140","32991794","2"],["32697968","32991794","2"],["32722908","32991794","2"],["32756549","32991794","2"],["9143688","33053279","2"],["32555134","33053279","2"],["32289263","33053279","2"],["32075877","33053279","2"],["31079849","33053279","2"],["28807998","33053279","2"],["26650692","33053279","2"],["26264835","33053279","2"],["24066892","32991794","2"],["25830322","33053279","2"],["23701746","33053279","2"],["20362616","33053279","2"],["19493565","33053279","2"],["18797453","33053279","2"],["15474494","33053279","2"],["15265895","33053279","2"],["15033360","33053279","2"],["25742465","33053279","2"],["32663912","33053279","2"],["21398392","32991794","2"],["18824060","32991794","2"],["14506376","32877576","2"],["32697968","32756549","2"],["32663912","32756549","2"],["32637598","32756549","2"],["32574299","32756549","2"],["32526206","32756549","2"],["32385100","32756549","2"],["32352406","32756549","2"],["32087114","32756549","2"],["32075877","32756549","2"],["31712433","32756549","2"],["31371616","32756549","2"],["30785039","32756549","2"],["30691364","32756549","2"],["29566112","32756549","2"],["19198616","32877576","2"],["20008423","32877576","2"],["22844480","32877576","2"],["26259809","32877576","2"],["18419349","32991794","2"],["17855683","32991794","2"],["32785213","32877576","2"],["32731257","32877576","2"],["32726528","32877576","2"],["32670071","32877576","2"],["32659783","32877576","2"],["20463105","32991794","2"],["32618497","32877576","2"],["32203189","32877576","2"],["32191675","32877576","2"],["32075877","32877576","2"],["31402384","32877576","2"],["29897849","32877576","2"],["28413427","32877576","2"],["26921779","32877576","2"],["32463443","32877576","2"],["32785213","33053279","2"],["32792628","33053279","2"],["32998157","33053279","2"],["32991794","33220855","2"],["32896291","33220855","2"],["32887977","33220855","2"],["32877576","33220855","2"],["32789505","33220855","2"],["32731258","33220855","2"],["32702299","33220855","2"],["32702298","33220855","2"],["32507409","33220855","2"],["32320465","33220855","2"],["32199492","33220855","2"],["32091533","33220855","2"],["31735500","33220855","2"],["30742894","33220855","2"],["29519670","33220855","2"],["33053279","33220855","2"],["33069281","33220855","2"],["18797453","33301246","2"],["26264835","33301246","2"],["33335322","33306989","2"],["33220855","33306989","2"],["33200120","33306989","2"],["33034689","33306989","2"],["32778354","33306989","2"],["32702298","33306989","2"],["32539990","33306989","2"],["27092831","33220855","2"],["32534626","33306989","2"],["25832102","33306989","2"],["15033648","33306989","2"],["33077678","33301246","2"],["33053279","33301246","2"],["32150748","33301246","2"],["32075877","33301246","2"],["31828291","33301246","2"],["32171076","33306989","2"],["25629663","33220855","2"],["22808149","33220855","2"],["17313487","33220855","2"],["30616012","33217362","2"],["27332149","33217362","2"],["26887309","33217362","2"],["22426327","33217362","2"],["15096554","33217362","2"],["32877576","33139139","2"],["32731258","33139139","2"],["32207377","33217362","2"],["32726802","33139139","2"],["32636454","33139139","2"],["32434946","33139139","2"],["32434945","33139139","2"],["32376603","33139139","2"],["32303590","33139139","2"],["32235945","33139139","2"],["32075877","33139139","2"],["32722908","33139139","2"],["29456015","32756549","2"],["32255761","33217362","2"],["32376603","33217362","2"],["16213065","33220855","2"],["16129869","33220855","2"],["6234369","33220855","2"],["33089772","33217362","2"],["33069281","33217362","2"],["33015650","33217362","2"],["32967006","33217362","2"],["32346146","33217362","2"],["32943637","33217362","2"],["32702298","33217362","2"],["32663912","33217362","2"],["32532802","33217362","2"],["32512579","33217362","2"],["32450106","33217362","2"],["32393526","33217362","2"],["32385100","33217362","2"],["32789505","33217362","2"],["17194199","27269431","2"],["29326426","32756549","2"],["29275847","32756549","2"],["32434945","32702298","2"],["32325038","32702298","2"],["32085823","32702298","2"],["31613649","32702298","2"],["31312806","32702298","2"],["31096710","32702298","2"],["30830861","32702298","2"],["30703077","32702298","2"],["29519670","32702298","2"],["29467399","32702298","2"],["26458833","32702298","2"],["25629663","32702298","2"],["22808149","32702298","2"],["21937658","32702298","2"],["15507655","32702298","2"],["32473127","32702298","2"],["32497196","32702298","2"],["32555388","32702298","2"],["32577525","32702298","2"],["32243722","32702299","2"],["32227757","32702299","2"],["32219428","32702299","2"],["32207377","32702299","2"],["32007143","32702299","2"],["30712865","32702299","2"],["28017642","32702299","2"],["32497196","32663912","2"],["22825819","32702299","2"],["20087930","32702299","2"],["17021110","32702299","2"],["14605137","32702299","2"],["32979941","32702298","2"],["32731258","32702298","2"],["32616673","32702298","2"],["32591408","32702298","2"],["21619905","32702299","2"],["32277878","32702299","2"],["32450106","32663912","2"],["32434945","32663912","2"],["18258008","32663912","2"],["17855683","32663912","2"],["26446606","27269431","2"],["26203246","27269431","2"],["25882242","27269431","2"],["25640653","27269431","2"],["25589660","27269431","2"],["25520500","27269431","2"],["4284810","18797453","2"],["24453361","27269431","2"],["22536382","27269431","2"],["21937658","27269431","2"],["20303868","27269431","2"],["19345285","27269431","2"],["18941225","27269431","2"],["22816037","32663912","2"],["23526951","32663912","2"],["26107625","32663912","2"],["26935699","32663912","2"],["32433465","32663912","2"],["32385100","32663912","2"],["32375025","32663912","2"],["32346146","32663912","2"],["32344679","32663912","2"],["32267220","32663912","2"],["32075877","32663912","2"],["32434946","32663912","2"],["31553909","32663912","2"],["31079849","32663912","2"],["30691364","32663912","2"],["30356097","32663912","2"],["29739835","32663912","2"],["29336703","32663912","2"],["28807998","32663912","2"],["28585916","32663912","2"],["31371616","32663912","2"],["32346093","32702299","2"],["32356867","32702299","2"],["32366511","32702299","2"],["6072745","32756549","2"],["4305198","32756549","2"],["32839763","32722908","2"],["32778225","32722908","2"],["32756549","32722908","2"],["32731258","32722908","2"],["32663912","32722908","2"],["32595632","32722908","2"],["32591408","32722908","2"],["32555424","32722908","2"],["32540903","32722908","2"],["32526206","32722908","2"],["32473127","32722908","2"],["32454512","32722908","2"],["32450106","32722908","2"],["15755610","32756549","2"],["16796401","32756549","2"],["16973594","32756549","2"],["17194199","32756549","2"],["29199281","32756549","2"],["28807998","32756549","2"],["28457665","32756549","2"],["28111638","32756549","2"],["27892925","32756549","2"],["27708058","32756549","2"],["26976607","32756549","2"],["32434946","32722908","2"],["26935699","32756549","2"],["26552008","32756549","2"],["26218507","32756549","2"],["24179220","32756549","2"],["24043791","32756549","2"],["23618766","32756549","2"],["21937658","32756549","2"],["20709108","32756549","2"],["26855426","32756549","2"],["32434945","32722908","2"],["32433465","32722908","2"],["32385100","32722908","2"],["28536429","32722908","2"],["28457665","32722908","2"],["28275193","32722908","2"],["27826140","32722908","2"],["27682426","32722908","2"],["24043791","32722908","2"],["23887981","32722908","2"],["28807998","32722908","2"],["22166544","32722908","2"],["14569023","32722908","2"],["12163607","32722908","2"],["32571838","32702299","2"],["32555424","32702299","2"],["32473127","32702299","2"],["32450106","32702299","2"],["32385100","32702299","2"],["18797453","32722908","2"],["29277291","32756549","2"],["29514901","32722908","2"],["30420505","32722908","2"],["32376603","32722908","2"],["32303590","32722908","2"],["32259480","32722908","2"],["32235945","32722908","2"],["32219057","32722908","2"],["32203366","32722908","2"],["32191675","32722908","2"],["29739835","32722908","2"],["32142651","32722908","2"],["32074444","32722908","2"],["31553909","32722908","2"],["31371616","32722908","2"],["30938227","32722908","2"],["30785039","32722908","2"],["30691364","32722908","2"],["30681265","32722908","2"],["32075877","32722908","2"],["1690918","18797453","2"]]},317:e=>{e.exports=[["PMID","title","journal","pubYear","nodeGroup","nCitedBy"],["31402384","Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.","The Journal of infectious diseases","2019","2","11"],["16873249","Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy.","Journal of virology","2006","2","111"],["31978945","A Novel Coronavirus from Patients with Pneumonia in China, 2019.","The New England journal of medicine","2020","2","5574"],["12393927","PHENIX: building new software for automated crystallographic structure determination.","Acta crystallographica. Section D, Biological crystallography","2002","2","2357"],["33220855","Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.","Lancet (London, England)","2020","1","36"],["29073020","Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion.","Proceedings of the National Academy of Sciences of the United States of America","2017","2","142"],["32637598","Impact of mRNA chemistry and manufacturing process on innate immune activation.","Science advances","2020","2","4"],["12781533","Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.","Lancet (London, England)","2003","2","411"],["32267220","Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.","Emerging infectious diseases","2020","2","372"],["22808149","A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.","PloS one","2012","2","100"],["32595632","Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.","Frontiers in immunology","2020","2","3"],["32967006","SARS-CoV-2 vaccines in development.","Nature","2020","2","92"],["21150709","Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.","Journal of immunotherapy (Hagerstown, Md. : 1997)","2011","2","84"],["29409570","Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","2018","2","43"],["12671062","A cluster of cases of severe acute respiratory syndrome in Hong Kong.","The New England journal of medicine","2003","2","474"],["18438401","A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.","Nature biotechnology","2008","2","335"],["16322745","Immunopathogenesis of coronavirus infections: implications for SARS.","Nature reviews. Immunology","2005","2","194"],["29066091","Influenza vaccination in tropical and subtropical areas.","The Lancet. Respiratory medicine","2017","2","8"],["27892925","A mouse model for MERS coronavirus-induced acute respiratory distress syndrome.","Nature microbiology","2016","2","96"],["29467399","Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.","Scientific reports","2018","2","14"],["29739835","Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.","The Journal of experimental medicine","2018","2","53"],["14996844","Structural characterization of the SARS-coronavirus spike S fusion protein core.","The Journal of biological chemistry","2004","2","110"],["32235945","Virological assessment of hospitalized patients with COVID-2019.","Nature","2020","2","1343"],["30703077","Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018.","MMWR. Morbidity and mortality weekly report","2019","2","10"],["24179220","Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.","Science (New York, N.Y.)","2013","2","306"],["28428558","A joint analysis of influenza-associated hospitalizations and mortality in Hong Kong, 1998-2013.","Scientific reports","2017","2","17"],["32731257","Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.","Nature","2020","2","96"],["25714138","Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review.","Human vaccines & immunotherapeutics","2015","2","20"],["32670071","Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy.","Frontiers in pharmacology","2020","2","2"],["18199635","Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.","Journal of virology","2008","2","81"],["26887309","[Immunological surrogate endpoints to evaluate vaccine efficacy].","Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]","2015","2","1"],["32203189","Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.","Cellular & molecular immunology","2020","2","320"],["15033648","A modified poisson regression approach to prospective studies with binary data.","American journal of epidemiology","2004","2","2525"],["11711632","Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.","Journal of virology","2001","2","17"],["26935699","Pre-fusion structure of a human coronavirus spike protein.","Nature","2016","2","236"],["32778225","Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.","Cell","2020","2","68"],["15210961","Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.","Proceedings of the National Academy of Sciences of the United States of America","2004","2","180"],["17913310","Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.","Vaccine","2007","2","60"],["32454512","A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.","Nature","2020","2","188"],["20110095","Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.","Virology","2010","2","69"],["31828291","Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","2020","1","11"],["24667168","Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.","PloS one","2014","2","138"],["23824369","Traditional and new influenza vaccines.","Clinical microbiology reviews","2013","2","116"],["26650692","Innate immune system activation by viral RNA: How to predict it?","Virology","2015","2","3"],["14976262","Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.","Science (New York, N.Y.)","2004","2","1107"],["31995857","Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.","The New England journal of medicine","2020","2","3642"],["20406307","Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.","Immunology","2010","2","33"],["16121363","A serological survey on neutralizing antibody titer of SARS convalescent sera.","Journal of medical virology","2005","2","31"],["25027661","A cationic nanoemulsion for the delivery of next-generation RNA vaccines.","Molecular therapy : the journal of the American Society of Gene Therapy","2014","2","66"],["31712433","mRNA structure regulates protein expression through changes in functional half-life.","Proceedings of the National Academy of Sciences of the United States of America","2019","2","15"],["27682426","Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus.","Scientific reports","2016","2","34"],["17537853","Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome.","Journal of virology","2007","2","187"],["25540984","Lipid-based mRNA vaccine delivery systems.","Expert review of vaccines","2014","2","40"],["33069281","Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.","The Lancet. Infectious diseases","2020","2","22"],["32839763","SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential.","Cell reports. Medicine","2020","2","20"],["26259809","A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.","The Journal of infectious diseases","2015","2","53"],["23542122","A simple method of mouse lung intubation.","Journal of visualized experiments : JoVE","2013","2","22"],["33139139","NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.","Vaccine","2020","1","20"],["30938227","Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein.","Emerging microbes & infections","2019","2","39"],["17931153","GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives.","Expert review of vaccines","2007","2","141"],["25697739","Clinical effectiveness of split-virion versus subunit trivalent influenza vaccines in older adults.","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","2015","2","14"],["25832102","Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.","BMJ (Clinical research ed.)","2015","2","6"],["15814718","Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.","Journal of immunology (Baltimore, Md. : 1950)","2005","2","135"],["28275193","Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.","Journal of virology","2017","2","32"],["18258008","Duration of antibody responses after severe acute respiratory syndrome.","Emerging infectious diseases","2007","2","106"],["30356097","Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis.","Scientific reports","2018","2","114"],["15827197","Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans.","Journal of virology","2005","2","122"],["29872003","ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps.","Acta crystallographica. Section D, Structural biology","2018","2","67"],["30785039","Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines.","Molecular therapy. Nucleic acids","2019","2","28"],["25640653","Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.","Cellular & molecular immunology","2015","2","69"],["29277291","Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease.","Virology","2017","2","20"],["16022774","SARS vaccine development.","Emerging infectious diseases","2005","2","79"],["14752165","Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China.","Science (New York, N.Y.)","2004","2","334"],["32726802","A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.","Nature","2020","2","45"],["18656518","The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.","Vaccine","2008","2","14"],["18991332","Inference by eye: reading the overlap of independent confidence intervals.","Statistics in medicine","2009","2","90"],["32325038","Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.","The Lancet. Infectious diseases","2020","2","40"],["25882242","Type 2 cytokines: mechanisms and therapeutic strategies.","Nature reviews. Immunology","2015","2","200"],["14506376","Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.","The Pediatric infectious disease journal","2003","2","37"],["15033360","Very fast folding and association of a trimerization domain from bacteriophage T4 fibritin.","Journal of molecular biology","2004","2","33"],["33034689","COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland.","Intensive care medicine","2020","2","11"],["32046819","Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020.","Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","2020","2","391"],["30691364","Structure-Based Vaccine Antigen Design.","Annual review of medicine","2019","2","25"],["17499378","Animal models and vaccines for SARS-CoV infection.","Virus research","2007","2","73"],["16586358","Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.","The Journal of infectious diseases","2006","2","36"],["32534626","Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.","Lancet (London, England)","2020","2","140"],["18562523","Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide.","Journal of virology","2008","2","117"],["28636855","Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.","The New England journal of medicine","2017","2","47"],["32722908","Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.","The New England journal of medicine","2020","1","92"],["14715271","A model of the ACE2 structure and function as a SARS-CoV receptor.","Biochemical and biophysical research communications","2004","2","71"],["29326426","mRNA vaccines - a new era in vaccinology.","Nature reviews. Drug discovery","2018","2","269"],["28935236","Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.","The Journal of infection","2017","2","31"],["12885899","The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.","Journal of virology","2003","2","504"],["16101349","Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus.","DNA and cell biology","2005","2","15"],["28585916","MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.","Emerging infectious diseases","2017","2","90"],["4305198","Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.","American journal of epidemiology","1969","2","601"],["27332149","Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus.","Emerging infectious diseases","2016","2","73"],["20008423","Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial.","Pediatrics","2009","2","59"],["15755610","Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets.","Vaccine","2005","2","89"],["8254673","Comparative protein modelling by satisfaction of spatial restraints.","Journal of molecular biology","1993","2","4452"],["4284810","Selective chemical modifications of uridine and pseudouridine in polynucleotides and their effect on the specificities of ribonuclease and phosphodiesterases.","Journal of the American Chemical Society","1965","2","8"],["25520500","Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.","Journal of virology","2014","2","72"],["24066892","Immune senescence and vaccination in the elderly.","Current topics in medicinal chemistry","2013","2","10"],["16039576","Cell type-specific involvement of RIG-I in antiviral response.","Immunity","2005","2","521"],["8627759","Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.","Journal of virology","1996","2","112"],["15043961","Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.","Lancet (London, England)","2004","2","220"],["33077678","Prospects for a safe COVID-19 vaccine.","Science translational medicine","2020","1","11"],["16476986","Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.","The Journal of general virology","2006","2","64"],["29109276","Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.","Proceedings of the National Academy of Sciences of the United States of America","2017","2","141"],["20080679","Lipid-like materials for low-dose, in vivo gene silencing.","Proceedings of the National Academy of Sciences of the United States of America","2010","2","263"],["32352406","Prototype pathogen approach for pandemic preparedness: world on fire.","The Journal of clinical investigation","2020","2","4"],["32142651","SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.","Cell","2020","2","3590"],["25119609","Efficacy of high-dose versus standard-dose influenza vaccine in older adults.","The New England journal of medicine","2014","2","175"],["14963300","Medicine. Caution urged on SARS vaccines.","Science (New York, N.Y.)","2004","2","47"],["21937658","A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.","Journal of virology","2011","1","174"],["31613649","Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials.","Expert review of vaccines","2019","2","6"],["23887981","Mixture models for single-cell assays with applications to vaccine studies.","Biostatistics (Oxford, England)","2013","2","28"],["18824060","A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.","Vaccine","2008","2","110"],["32616673","Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.","Science (New York, N.Y.)","2020","2","98"],["33301246","Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.","The New England journal of medicine","2020","0","162"],["1546298","Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA.","Science (New York, N.Y.)","1992","2","39"],["32640463","Factors associated with COVID-19-related death using OpenSAFELY.","Nature","2020","2","385"],["15194798","An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.","Journal of virology","2004","2","57"],["32618497","High neutralizing antibody titer in intensive care unit patients with COVID-19.","Emerging microbes & infections","2020","2","21"],["20709108","Generation of VSV pseudotypes using recombinant Î”G-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines.","Journal of virological methods","2010","2","94"],["31591575","Real-time cryo-electron microscopy data preprocessing with Warp.","Nature methods","2019","2","65"],["33200120","Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.","EClinicalMedicine","2020","2","10"],["27025838","A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","2016","2","70"],["32255761","High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2.","Emerging infectious diseases","2020","2","286"],["19036930","Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice.","Proceedings of the National Academy of Sciences of the United States of America","2008","2","110"],["17515829","Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple.","Pediatric research","2007","2","23"],["29275847","Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses.","Molecular therapy : the journal of the American Society of Gene Therapy","2017","2","59"],["32979941","Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.","Cell","2020","2","169"],["15530413","Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.","Biochemical and biophysical research communications","2004","2","72"],["22536382","Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.","PloS one","2012","1","195"],["26218507","Evaluation of candidate vaccine approaches for MERS-CoV.","Nature communications","2015","2","149"],["22426327","Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial.","Vaccine","2012","2","38"],["15474494","Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine.","Biochemical and biophysical research communications","2004","2","175"],["32507409","Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.","Vaccine","2020","2","24"],["16954221","Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.","The Journal of biological chemistry","2006","2","100"],["18941225","Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.","Journal of immunology (Baltimore, Md. : 1950)","2008","2","93"],["15367630","Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.","Journal of virology","2004","2","110"],["18981084","Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease.","Journal of immunology (Baltimore, Md. : 1950)","2008","2","30"],["16461566","Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients.","Journal of clinical pathology","2006","2","17"],["28807998","Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.","Proceedings of the National Academy of Sciences of the United States of America","2017","2","230"],["32091533","Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72â€¯314 Cases From the Chinese Center for Disease Control and Prevention.","JAMA","2020","2","3911"],["23296925","In vitro transcription of long RNA containing modified nucleosides.","Methods in molecular biology (Clifton, N.J.)","2013","2","28"],["32065055","Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.","Emerging microbes & infections","2020","2","407"],["22166544","RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues.","The Journal of molecular diagnostics : JMD","2012","2","669"],["9143688","Neutralizing antiviral B cell responses.","Annual review of immunology","1997","2","131"],["21762752","Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.","Vaccine","2011","2","42"],["32726528","Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.","The New England journal of medicine","2020","2","12"],["29456015","Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.","Vaccine","2018","2","32"],["16195440","Virology. Researchers tie deadly SARS virus to bats.","Science (New York, N.Y.)","2005","2","10"],["32756549","SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.","Nature","2020","1","85"],["30216647","Seasonal influenza immunisation: Strategies for older adults.","International journal of clinical practice","2018","2","6"],["6072745","Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines.","JAMA","1967","2","84"],["19393959","Incubation periods of acute respiratory viral infections: a systematic review.","The Lancet. Infectious diseases","2009","2","255"],["20876821","How innate immune mechanisms contribute to antibody-enhanced viral infections.","Clinical and vaccine immunology : CVI","2010","2","51"],["32064853","[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].","Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi","2020","2","995"],["15837235","Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults.","Vaccine","2005","2","21"],["16169905","Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats.","Proceedings of the National Academy of Sciences of the United States of America","2005","2","678"],["33089772","Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020.","Emerging infectious diseases","2020","2","6"],["32171076","Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","Lancet (London, England)","2020","2","6093"],["22825819","Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China.","Journal of medical virology","2012","2","14"],["27269431","Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus.","Human vaccines & immunotherapeutics","2016","1","97"],["12925421","Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada.","CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","2003","2","160"],["32792628","A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.","Nature communications","2020","2","24"],["19297479","Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2.","Journal of virology","2009","2","22"],["23159882","Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.","Nature biotechnology","2012","2","116"],["29519670","Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults.","EBioMedicine","2018","2","39"],["22908294","Nonviral delivery of self-amplifying RNA vaccines.","Proceedings of the National Academy of Sciences of the United States of America","2012","2","148"],["27775012","Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia.","Scientific reports","2016","2","22"],["29897849","Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.","The New England journal of medicine","2018","2","11"],["1889744","Modulation of firefly luciferase stability and impact on studies of gene regulation.","Gene","1991","2","123"],["32577525","A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques.","Science advances","2020","2","17"],["15547138","Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails.","RNA (New York, N.Y.)","2004","2","49"],["32555424","Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.","Nature medicine","2020","2","481"],["32555134","Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.","MMWR. Morbidity and mortality weekly report","2020","2","154"],["10918485","Sodium phosphate enhances plasmid DNA expression in vivo.","Gene therapy","2000","2","13"],["32075877","Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.","Science (New York, N.Y.)","2020","1","1802"],["28393837","Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains.","Nature communications","2017","2","249"],["32303590","Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.","Science (New York, N.Y.)","2020","2","218"],["10918143","Optimization of repeated-batch transcription for RNA production.","Biotechnology and bioengineering","2000","2","1"],["25233993","mRNA-based therapeutics--developing a new class of drugs.","Nature reviews. Drug discovery","2014","2","272"],["32346146","The race for coronavirus vaccines: a graphical guide.","Nature","2020","2","76"],["15096554","Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection.","Journal of medical microbiology","2004","2","26"],["26552008","A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.","Nature medicine","2015","2","245"],["16035944","Vaccine design for severe acute respiratory syndrome coronavirus.","Viral immunology","2005","2","16"],["20374001","A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity.","Viral immunology","2010","2","27"],["19420084","Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection.","Journal of virology","2009","2","79"],["15024391","A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.","Nature","2004","2","329"],["28165473","cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination.","Nature methods","2017","2","650"],["9175832","IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice.","Immunity","1997","2","86"],["32385100","Rapid COVID-19 vaccine development.","Science (New York, N.Y.)","2020","2","105"],["12711465","Coronavirus as a possible cause of severe acute respiratory syndrome.","Lancet (London, England)","2003","2","1395"],["33015650","Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.","Cell reports. Medicine","2020","2","20"],["15205534","Promotion of B cell immune responses via an alum-induced myeloid cell population.","Science (New York, N.Y.)","2004","2","77"],["7962541","Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.","The Journal of clinical investigation","1994","2","50"],["14567964","Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.","Molecular genetics and metabolism","2003","2","371"],["33217362","Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.","The Lancet. Infectious diseases","2020","1","26"],["30551178","Comparative Immunogenicity of Enhanced Seasonal Influenza Vaccines in Older Adults: A Systematic Review and Meta-analysis.","The Journal of infectious diseases","2019","2","10"],["16796401","Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.","PLoS medicine","2006","2","207"],["12927681","Purine and pyrimidine metabolites in children's urine.","Clinica chimica acta; international journal of clinical chemistry","2003","2","9"],["30742894","Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.","The Journal of infection","2019","2","10"],["18419349","Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.","The Journal of infectious diseases","2008","2","113"],["32346093","The trinity of COVID-19: immunity, inflammation and intervention.","Nature reviews. Immunology","2020","2","676"],["31986261","A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.","Lancet (London, England)","2020","2","2306"],["16597622","Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody.","The Journal of biological chemistry","2006","2","125"],["18753223","Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.","The Journal of general virology","2008","2","41"],["18018769","Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine.","Antiviral therapy","2007","2","64"],["31504163","Automatic local resolution-based sharpening of cryo-EM maps.","Bioinformatics (Oxford, England)","2020","2","19"],["17932806","mRNA-based gene transfer as a tool for gene and cell therapy.","Current opinion in molecular therapeutics","2007","2","37"],["31096710","Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine.","Vaccines","2019","2","5"],["17108019","Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor.","Journal of virology","2006","2","109"],["15265895","IFN-alpha subtypes differentially affect human T cell motility.","Journal of immunology (Baltimore, Md. : 1950)","2004","2","23"],["12574374","IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.","Journal of immunology (Baltimore, Md. : 1950)","2003","2","43"],["29513216","<i>cis</i>TEM, user-friendly software for single-particle image processing.","eLife","2018","2","196"],["26921779","Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.","Vaccine","2016","2","28"],["17855683","Disappearance of antibodies to SARS-associated coronavirus after recovery.","The New England journal of medicine","2007","2","104"],["12958366","Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.","Science (New York, N.Y.)","2003","2","926"],["32731258","ChAdOx1Â nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.","Nature","2020","1","167"],["33306989","Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.","Lancet (London, England)","2020","1","75"],["29348656","Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases.","Scientific reports","2018","2","5"],["15695582","Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human.","Proceedings of the National Academy of Sciences of the United States of America","2005","2","300"],["31996437","Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.","Journal of virology","2020","2","1117"],["20303868","Asthma and allergic inflammation.","Cell","2010","2","145"],["33378609","Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.","The New England journal of medicine","2020","0","62"],["26038486","Rapidly produced SAM(Â®) vaccine against H7N9 influenza is immunogenic in mice.","Emerging microbes & infections","2013","2","70"],["32998157","COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responses.","Nature","2020","2","51"],["7839312","Properties of inhibitory and excitatory synapses between hippocampal neurons in very low density cultures.","Synapse (New York, N.Y.)","1994","2","37"],["22816037","Mechanisms of coronavirus cell entry mediated by the viral spike protein.","Viruses","2012","2","339"],["32003551","Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.","The New England journal of medicine","2020","2","1161"],["32574299","COVID-19: Emergence, Spread, Possible Treatments, and Global Burden.","Frontiers in public health","2020","2","16"],["32219428","Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.","JAMA","2020","2","742"],["19321428","Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.","Proceedings of the National Academy of Sciences of the United States of America","2009","2","317"],["16968120","SARS: systematic review of treatment effects.","PLoS medicine","2006","2","462"],["33053279","Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.","The New England journal of medicine","2020","1","76"],["22032844","Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.","The Lancet. Infectious diseases","2011","1","646"],["29199281","Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic.","Nature immunology","2017","2","26"],["19176631","Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.","Journal of virology","2009","2","33"],["15264254","UCSF Chimera--a visualization system for exploratory research and analysis.","Journal of computational chemistry","2004","2","11535"],["25629663","A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.","The New England journal of medicine","2015","2","145"],["16973594","Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.","Journal of virology","2006","2","190"],["15150417","Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.","Proceedings of the National Academy of Sciences of the United States of America","2004","2","172"],["32697968","Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.","Cell","2020","2","452"],["26855426","Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer.","Nature","2016","2","190"],["15314040","A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.","International immunology","2004","2","60"],["31534041","The 3.1-Angstrom Cryo-electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation.","Journal of virology","2019","2","14"],["32085823","Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.","Lancet (London, England)","2020","2","8"],["32702298","Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.","Lancet (London, England)","2020","1","262"],["21703402","Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis.","The American journal of pathology","2011","2","293"],["32007145","Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.","Lancet (London, England)","2020","2","2794"],["16111635","Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.","Immunity","2005","2","348"],["19345285","A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis.","Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association","2009","2","73"],["21632986","MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.","Science translational medicine","2011","2","143"],["29566112","Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases.","JAMA","2018","2","22"],["26203246","Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages.","International journal of nanomedicine","2015","2","9"],["28008928","Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding.","Cell research","2016","2","179"],["8559660","Stabilization of RNA stacking by pseudouridine.","Nucleic acids research","1995","2","135"],["15096611","Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.","Proceedings of the National Academy of Sciences of the United States of America","2004","2","232"],["32539990","A minimal common outcome measure set for COVID-19 clinical research.","The Lancet. Infectious diseases","2020","2","51"],["32207377","Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.","Emerging microbes & infections","2020","2","120"],["14670965","A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.","The Journal of biological chemistry","2003","2","336"],["27092831","Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.","JAMA","2016","2","99"],["14976261","Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.","Science (New York, N.Y.)","2004","2","1067"],["26446606","Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease.","Journal of virology","2015","2","47"],["32087114","An interactive web-based dashboard to track COVID-19 in real time.","The Lancet. Infectious diseases","2020","2","1358"],["28413427","Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.","Immunity & ageing : I & A","2017","2","22"],["32191675","WHO Declares COVID-19 a Pandemic.","Acta bio-medica : Atenei Parmensis","2020","2","528"],["25742465","Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.","JAMA","2015","2","40"],["15504263","Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China.","Emerging infectious diseases","2004","2","68"],["32877576","Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.","The New England journal of medicine","2020","1","91"],["18071662","Vaccination with messenger RNA (mRNA).","Handbook of experimental pharmacology","2008","2","29"],["21398392","A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.","The Journal of infectious diseases","2011","2","62"],["19493565","Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.","Lancet (London, England)","2009","2","138"],["17227689","Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV).","Vaccine","2006","2","16"],["31371616","A proof of concept for structure-based vaccine design targeting RSV in humans.","Science (New York, N.Y.)","2019","2","40"],["28635557","Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison.","Human vaccines & immunotherapeutics","2017","2","10"],["32199492","Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.","The Lancet. Infectious diseases","2020","2","4"],["20087930","The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines.","Journal of medical virology","2010","2","15"],["26465999","Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults.","The New England journal of medicine","2015","1","10"],["27617430","Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy.","Nature structural & molecular biology","2016","2","136"],["17194199","Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants.","PLoS medicine","2006","2","137"],["15731223","Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents.","Journal of virology","2005","2","56"],["17038590","5'-Triphosphate RNA is the ligand for RIG-I.","Science (New York, N.Y.)","2006","2","944"],["20980507","Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.","Journal of virology","2010","2","43"],["22278370","Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins.","Molecular & cellular proteomics : MCP","2012","2","286"],["21755013","Bacteria-specific neutrophil dysfunction associated with interferon-stimulated gene expression in the acute respiratory distress syndrome.","PloS one","2011","2","9"],["15749124","Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.","Virology","2005","2","65"],["9814710","Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation.","Cell","1998","2","215"],["32273591","The COVID-19 vaccine development landscape.","Nature reviews. Drug discovery","2020","1","347"],["16214268","A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.","Vaccine","2005","2","64"],["33335322","Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.","Nature medicine","2020","2","7"],["27626517","Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.","The New England journal of medicine","2016","1","177"],["27061888","Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.","The Lancet. Infectious diseases","2016","2","176"],["17200946","Immunosenescence of ageing.","The Journal of pathology","2007","2","242"],["25589660","Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease.","Journal of virology","2015","2","121"],["32289263","An Infectious cDNA Clone of SARS-CoV-2.","Cell host & microbe","2020","2","73"],["32636454","Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.","Cell research","2020","2","45"],["15507655","Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets.","Journal of virology","2004","2","156"],["16505353","Mucosal and systemic adjuvant activity of alphavirus replicon particles.","Proceedings of the National Academy of Sciences of the United States of America","2006","2","54"],["29336703","Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field.","Viral immunology","2018","2","7"],["32926660","Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).","Toxicologic pathology","2020","1","1"],["32375025","Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.","Cell","2020","2","89"],["16690096","Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients.","Virology","2006","2","65"],["11599686","Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects.","European journal of epidemiology","2001","2","27"],["32219057","The SARS-CoV-2 Vaccine Pipeline: an Overview.","Current tropical medicine reports","2020","2","138"],["32943637","A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.","Nature communications","2020","2","118"],["23526951","Risk in vaccine research and development quantified.","PloS one","2013","2","49"],["26107625","Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children.","PloS one","2015","2","22"],["32356867","Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.","JAMA internal medicine","2020","2","128"],["15233739","Cancer immunotherapy with mRNA-transfected dendritic cells.","Immunological reviews","2004","2","82"],["15642942","Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses.","Proceedings of the National Academy of Sciences of the United States of America","2005","2","132"],["17222058","A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.","PLoS pathogens","2007","2","234"],["32079150","Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.","Journal of clinical medicine","2020","2","282"],["16129869","A global clinical measure of fitness and frailty in elderly people.","CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","2005","2","1178"],["32659783","A perspective on potential antibody-dependent enhancement of SARS-CoV-2.","Nature","2020","2","67"],["23799535","Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics.","Molecular therapy : the journal of the American Society of Gene Therapy","2013","2","68"],["12734147","Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.","JAMA","2003","2","592"],["6234369","Hepatitis-B vaccination in the elderly.","The Journal of infectious diseases","1984","2","25"],["28931244","The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.","The Journal of infectious diseases","2017","2","37"],["29514901","Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.","Journal of virology","2018","2","71"],["32450106","Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.","Lancet (London, England)","2020","2","258"],["20883165","Immunogenicity and protective efficacy in mice and hamsters of a Î²-propiolactone inactivated whole virus SARS-CoV vaccine.","Viral immunology","2010","2","21"],["31351922","Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.","The Lancet. Infectious diseases","2019","2","78"],["28017642","Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial.","The Lancet. Global health","2016","2","17"],["15572765","Coot: model-building tools for molecular graphics.","Acta crystallographica. Section D, Biological crystallography","2004","2","13441"],["29402578","Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.","Vaccine","2018","2","8"],["30420505","Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.","Proceedings of the National Academy of Sciences of the United States of America","2018","2","18"],["4305197","An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.","American journal of epidemiology","1969","2","334"],["26458833","Laboratory-Scale Production of Replication-Deficient Adenovirus Vectored Vaccines.","Methods in molecular biology (Clifton, N.J.)","2016","2","5"],["27708058","Rapid development of a DNA vaccine for Zika virus.","Science (New York, N.Y.)","2016","2","169"],["32150748","The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.","Annals of internal medicine","2020","1","1110"],["26264835","Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.","Journal of controlled release : official journal of the Controlled Release Society","2015","1","110"],["6754243","Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever.","Comparative immunology, microbiology and infectious diseases","1981","2","113"],["32532802","The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries.","Science (New York, N.Y.)","2020","2","129"],["22782619","Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo.","Angewandte Chemie (International ed. in English)","2012","2","144"],["14983044","Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.","Proceedings of the National Academy of Sciences of the United States of America","2004","2","305"],["14569023","Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.","Proceedings of the National Academy of Sciences of the United States of America","2003","2","217"],["32473127","Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.","Cell","2020","2","537"],["32702299","Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.","Lancet (London, England)","2020","1","135"],["16195424","Bats are natural reservoirs of SARS-like coronaviruses.","Science (New York, N.Y.)","2005","2","947"],["28457665","Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.","Molecular therapy : the journal of the American Society of Gene Therapy","2017","2","118"],["19879222","Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons &gt; or =65 years old.","Vaccine","2009","2","13"],["15655773","Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.","The Journal of infectious diseases","2005","2","81"],["11162792","Coronavirus spike proteins in viral entry and pathogenesis.","Virology","2001","2","300"],["32526206","SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.","Cell","2020","2","173"],["32057769","The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.","Antiviral research","2020","2","419"],["16670345","T cell responses are better correlates of vaccine protection in the elderly.","Journal of immunology (Baltimore, Md. : 1950)","2006","2","210"],["12730500","Characterization of a novel coronavirus associated with severe acute respiratory syndrome.","Science (New York, N.Y.)","2003","2","1321"],["32512579","Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.","Nature","2020","2","246"],["16497416","A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice.","Vaccine","2006","2","43"],["20977431","Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549).","Cell biology international","2011","2","9"],["26976607","SARS-like WIV1-CoV poised for human emergence.","Proceedings of the National Academy of Sciences of the United States of America","2016","2","149"],["28536429","A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.","Emerging microbes & infections","2017","2","22"],["20362616","Ageing and immunity: addressing immune senescence to ensure healthy ageing.","Vaccine","2010","2","17"],["19800030","Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses.","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","2009","2","18"],["21890902","Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.","Nucleic acids research","2011","2","114"],["19609242","Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.","Journal of immunotherapy (Hagerstown, Md. : 1997)","2009","2","74"],["12690091","Identification of a novel coronavirus in patients with severe acute respiratory syndrome.","The New England journal of medicine","2003","2","1937"],["17620608","Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.","Proceedings of the National Academy of Sciences of the United States of America","2007","2","146"],["17917067","Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.","Immunologic research","2007","2","56"],["19234811","Differential characteristics of the early stage of lung inflammation induced by SARS-CoV Nucleocapsid protein related to age in the mouse.","Inflammation research : official journal of the European Histamine Research Society ... [et al.]","2009","2","5"],["17928346","Viral and host factors in human respiratory syncytial virus pathogenesis.","Journal of virology","2007","2","221"],["18797453","Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.","Molecular therapy : the journal of the American Society of Gene Therapy","2008","1","221"],["32015507","A pneumonia outbreak associated with a new coronavirus of probable bat origin.","Nature","2020","2","4308"],["30712865","Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion.","Cell","2019","2","172"],["15268662","Messenger RNA-based vaccines.","Expert opinion on biological therapy","2004","2","33"],["12682352","A major outbreak of severe acute respiratory syndrome in Hong Kong.","The New England journal of medicine","2003","2","979"],["15078936","Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.","Journal of virology","2004","2","115"],["24043791","Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.","Proceedings of the National Academy of Sciences of the United States of America","2013","2","150"],["24850731","Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.","Journal of virology","2014","2","51"],["12865378","Critically ill patients with severe acute respiratory syndrome.","JAMA","2003","2","131"],["8552671","In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3' untranslated regions of human alpha-tropomyosin.","Proceedings of the National Academy of Sciences of the United States of America","1996","2","38"],["15731234","B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.","Journal of virology","2005","2","48"],["17507479","Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.","Journal of virology","2007","2","45"],["15791205","Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.","The EMBO journal","2005","2","389"],["12235218","A role for immune complexes in enhanced respiratory syncytial virus disease.","The Journal of experimental medicine","2002","2","139"],["26802140","Long-term Protection After Hepatitis B Vaccine.","The Journal of infectious diseases","2016","2","17"],["30616012","Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial.","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","2019","2","2"],["15208624","The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.","Nature immunology","2004","2","1444"],["31553909","Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD.","Cell reports","2019","2","24"],["32227757","Developing Covid-19 Vaccines at Pandemic Speed.","The New England journal of medicine","2020","1","278"],["17037596",'Resurrection of an "extinct" SARS-CoV isolate GD03 from late 2003.',"Advances in experimental medicine and biology","2006","2","5"],["32259480","SARS-CoV-2 Vaccines: Status Report.","Immunity","2020","2","308"],["15054081","Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein.","Clinical chemistry","2004","2","37"],["7836924","T cell genetic background determines default T helper phenotype development in vitro.","The Journal of experimental medicine","1995","2","114"],["11607032","Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.","Nature","2001","2","1767"],["20463105","Correlates of protection induced by vaccination.","Clinical and vaccine immunology : CVI","2010","2","473"],["23618766","Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody.","Science (New York, N.Y.)","2013","2","296"],["15577937","Severe acute respiratory syndrome.","Nature medicine","2004","2","448"],["27826140","Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China.","Emerging microbes & infections","2016","2","16"],["8901605","Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses.","Proceedings of the National Academy of Sciences of the United States of America","1996","2","39"],["32243722","Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection.","Pediatric pulmonology","2020","2","14"],["31735500","A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.","Vaccine","2019","2","8"],["15016880","Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.","Journal of virology","2004","2","225"],["20461061","Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.","Molecular therapy : the journal of the American Society of Gene Therapy","2010","2","210"],["32366511","Developing a vaccine for covid-19.","BMJ (Clinical research ed.)","2020","2","9"],["25359562","mRNA transcript therapy.","Expert review of vaccines","2014","2","30"],["19598148","Estimating incubation period distributions with coarse data.","Statistics in medicine","2009","2","43"],["12730501","The Genome sequence of the SARS-associated coronavirus.","Science (New York, N.Y.)","2003","2","1110"],["12781535","Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.","Lancet (London, England)","2003","2","1078"],["32778354","Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention.","American journal of preventive medicine","2020","2","17"],["32277878","First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment.","Lancet (London, England)","2020","2","186"],["16862151","A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines.","Nature medicine","2006","2","85"],["23701746","Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers.","Vaccine","2013","2","23"],["32214079","Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.","MMWR. Morbidity and mortality weekly report","2020","2","544"],["32663912","An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.","The New England journal of medicine","2020","1","310"],["17515642","Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responses.","Japanese journal of infectious diseases","2007","2","12"],["16731915","Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.","Journal of virology","2006","1","57"],["19198616","The spike protein of SARS-CoV--a target for vaccine and therapeutic development.","Nature reviews. Microbiology","2009","2","473"],["32540903","Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.","Science (New York, N.Y.)","2020","2","226"],["10037236","An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.","Journal of immunological methods","1999","2","1044"],["18191004","Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV.","Vaccine","2007","2","37"],["32540900","Broad neutralization of SARS-related viruses by human monoclonal antibodies.","Science (New York, N.Y.)","2020","2","98"],["32344679","The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control.","Journal of clinical medicine","2020","2","68"],["30102747","Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.","PLoS pathogens","2018","2","221"],["32376603","Development of an inactivated vaccine candidate for SARS-CoV-2.","Science (New York, N.Y.)","2020","2","256"],["15650189","Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.","Journal of virology","2005","2","68"],["32497196","Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","2020","2","58"],["32433465","Immunogenicity of a DNA vaccine candidate for COVID-19.","Nature communications","2020","2","110"],["25078002","Beyond D-luciferin: expanding the scope of bioluminescence imaging in vivo.","Current opinion in chemical biology","2014","2","47"],["32785213","PhaseÂ I/II study of COVID-19 RNA vaccine BNT162b1 in adults.","Nature","2020","2","91"],["32007143","Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","Lancet (London, England)","2020","2","4980"],["17313487","Immunosenescence: emerging challenges for an ageing population.","Immunology","2007","2","197"],["21325420","Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.","Journal of virology","2011","2","338"],["12748314","SARS-associated coronavirus.","The New England journal of medicine","2003","2","131"],["27578435","Structure, Function, and Evolution of Coronavirus Spike Proteins.","Annual review of virology","2016","2","558"],["32896291","Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.","Lancet (London, England)","2020","2","77"],["11121305","Leginon: an automated system for acquisition of images from vitreous ice specimens.","Journal of structural biology","2000","2","93"],["24040512","Collaboration gets the most out of software.","eLife","2013","2","339"],["29069368","Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong.","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","2018","2","5"],["30830861","Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.","JCI insight","2019","2","263"],["32463443","RSV neutralizing antibodies at birth predict protection from RSV illness in infants in the first three months of life.","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","2020","2","3"],["20960282","Immunogenicity of the spike glycoprotein of bat SARS-like coronavirus.","Virologica Sinica","2010","2","2"],["30681265","OMIP-052: An 18-Color Panel for Measuring Th1, Th2, Th17, and Tfh Responses in Rhesus Macaques.","Cytometry. Part A : the journal of the International Society for Analytical Cytology","2019","2","1"],["1690918","Direct gene transfer into mouse muscle in vivo.","Science (New York, N.Y.)","1990","2","610"],["14647384","Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.","Nature","2003","2","1993"],["15708987","Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.","Journal of virology","2005","2","114"],["32555388","Convergent antibody responses to SARS-CoV-2 in convalescent individuals.","Nature","2020","2","278"],["15220038","Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets.","Lancet (London, England)","2004","2","137"],["16166518","Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.","Science (New York, N.Y.)","2005","2","682"],["17416434","Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.","Virus research","2007","2","63"],["16213065","Antibody response to influenza vaccination in the elderly: a quantitative review.","Vaccine","2005","2","342"],["15286725","Fibrotic disease and the T(H)1/T(H)2 paradigm.","Nature reviews. Immunology","2004","2","518"],["12690092","A novel coronavirus associated with severe acute respiratory syndrome.","The New England journal of medicine","2003","2","1910"],["18582997","Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.","Vaccine","2008","2","21"],["17344286","Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells.","Journal of virology","2007","2","34"],["19079256","Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease.","Nature medicine","2008","2","199"],["32434945","DNA vaccine protection against SARS-CoV-2 in rhesus macaques.","Science (New York, N.Y.)","2020","2","225"],["15161975","Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.","Proceedings of the National Academy of Sciences of the United States of America","2004","2","54"],["21619905","International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.","Vaccine","2011","2","107"],["17021110","Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa.","Journal of clinical microbiology","2006","2","57"],["31986264","Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","Lancet (London, England)","2020","2","9912"],["31312806","Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).","EClinicalMedicine","2019","2","12"],["32434946","SARS-CoV-2 infection protects against rechallenge in rhesus macaques.","Science (New York, N.Y.)","2020","2","193"],["14605137","Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.","Journal of clinical microbiology","2003","2","91"],["17108024","Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists.","Journal of virology","2006","2","294"],["32203366","The coronavirus pandemic in five powerful charts.","Nature","2020","2","61"],["23306021","Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format.","Journal of controlled release : official journal of the Controlled Release Society","2013","2","45"],["30501873","Vaccination in the elderly: The challenge of immune changes with aging.","Seminars in immunology","2018","2","35"],["32591408","Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.","Science immunology","2020","2","157"],["32789505","Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.","JAMA","2020","2","65"],["24453361","Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus.","Journal of virology","2014","2","26"],["15670750","The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse.","Biochemical and biophysical research communications","2005","2","22"],["19181630","Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model.","Toxicologic pathology","2009","2","53"],["12163607","Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.","Journal of virology","2002","2","238"],["32887977","Broad and strong memory CD4<sup>+</sup> and CD8<sup>+</sup> T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.","Nature immunology","2020","2","84"],["31079849","mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials.","Vaccine","2019","2","48"],["15381196","Cellular entry of the SARS coronavirus.","Trends in microbiology","2004","2","84"],["23051623","Manual restraint and common compound administration routes in mice and rats.","Journal of visualized experiments : JoVE","2012","2","29"],["16732888","Characterization of the ribonuclease activity on the skin surface.","Genetic vaccines and therapy","2006","2","18"],["15220033","Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.","Lancet (London, England)","2004","2","147"],["15155925","Infectious diseases. One year after outbreak, SARS virus yields some secrets.","Science (New York, N.Y.)","2004","2","13"],["15194770","Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.","Journal of virology","2004","2","87"],["15356154","Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.","Journal of immunology (Baltimore, Md. : 1950)","2004","2","77"],["28111638","Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors.","Science immunology","2016","2","58"],["32991794","Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.","The New England journal of medicine","2020","1","80"],["14675530","The secret life of ACE2 as a receptor for the SARS virus.","Cell","2003","2","58"],["27346939","Available influenza vaccines: immunization strategies, history and new tools for fighting the disease.","Journal of preventive medicine and hygiene","2016","2","11"],["14681510","The severe acute respiratory syndrome.","The New England journal of medicine","2003","2","507"],["12184362","Mechanisms of stimulation of the immune response by aluminum adjuvants.","Vaccine","2002","2","72"],["23296926","HPLC purification of in vitro transcribed long RNA.","Methods in molecular biology (Clifton, N.J.)","2013","2","29"],["25830322","A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.","The New England journal of medicine","2015","2","142"],["22844480","Matrix-Mâ„¢ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen.","PloS one","2012","2","23"],["22095567","Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination.","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","2011","1","20"],["32320465","Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged â‰¥60 Years.","The Journal of infectious diseases","2020","2","4"],["14729660","mRNA is an endogenous ligand for Toll-like receptor 3.","The Journal of biological chemistry","2004","2","311"],["8522182","The tobacco etch viral 5' leader and poly(A) tail are functionally synergistic regulators of translation.","Gene","1995","2","35"],["12774078","Virus detectives seek source of SARS in China's wild animals.","Nature","2003","2","14"],["19888339","A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.","PLoS pathogens","2009","2","116"],["29471464","Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","2018","2","15"],["9518670","Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA.","Biochimica et biophysica acta","1998","2","12"],["32393526","A strategic approach to COVID-19 vaccine R&amp;D.","Science (New York, N.Y.)","2020","2","73"],["32074444","SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.","The New England journal of medicine","2020","2","1416"],["18463152","A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters.","Journal of virology","2008","2","70"],["15324552","Mice susceptible to SARS coronavirus.","Emerging infectious diseases","2004","2","40"],["32571838","A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.","Science (New York, N.Y.)","2020","2","158"],["14564000","LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.","Science (New York, N.Y.)","2003","2","1100"],["32015508","A new coronavirus associated with human respiratory disease in China.","Nature","2020","2","1951"],["16254327","Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization.","Journal of virology","2005","2","26"]]},600:(e,i,n)=>{"use strict";var o=n(3379),a=n.n(o),t=n(2443),r=a()(t.default,{insert:"head",singleton:!1});if(!t.default.locals||e.hot.invalidate){var s=t.default.locals;e.hot.accept(2443,(i=>{t=n(2443),function(e,i,n){if(!e&&i||e&&!i)return!1;var o;for(o in e)if(e[o]!==i[o])return!1;for(o in i)if(!e[o])return!1;return!0}(s,t.default.locals)?(s=t.default.locals,r(t.default)):e.hot.invalidate()}))}e.hot.dispose((function(){r()})),t.default.locals},1530:(e,i,n)=>{"use strict";var o=n(3379),a=n.n(o),t=n(4214),r=a()(t.default,{insert:"head",singleton:!1});if(!t.default.locals||e.hot.invalidate){var s=t.default.locals;e.hot.accept(4214,(i=>{t=n(4214),function(e,i,n){if(!e&&i||e&&!i)return!1;var o;for(o in e)if(e[o]!==i[o])return!1;for(o in i)if(!e[o])return!1;return!0}(s,t.default.locals)?(s=t.default.locals,r(t.default)):e.hot.invalidate()}))}e.hot.dispose((function(){r()})),t.default.locals},5057:(e,i,n)=>{"use strict";var o=n(3379),a=n.n(o),t=n(5115),r=a()(t.default,{insert:"head",singleton:!1});if(!t.default.locals||e.hot.invalidate){var s=t.default.locals;e.hot.accept(5115,(i=>{t=n(5115),function(e,i,n){if(!e&&i||e&&!i)return!1;var o;for(o in e)if(e[o]!==i[o])return!1;for(o in i)if(!e[o])return!1;return!0}(s,t.default.locals)?(s=t.default.locals,r(t.default)):e.hot.invalidate()}))}e.hot.dispose((function(){r()})),t.default.locals},1938:(e,i,n)=>{"use strict";var o=n(3379),a=n.n(o),t=n(2646),r=a()(t.default,{insert:"head",singleton:!1});if(!t.default.locals||e.hot.invalidate){var s=t.default.locals;e.hot.accept(2646,(i=>{t=n(2646),function(e,i,n){if(!e&&i||e&&!i)return!1;var o;for(o in e)if(e[o]!==i[o])return!1;for(o in i)if(!e[o])return!1;return!0}(s,t.default.locals)?(s=t.default.locals,r(t.default)):e.hot.invalidate()}))}e.hot.dispose((function(){r()})),t.default.locals}}]);
//# sourceMappingURL=Section3.js.map